This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other necrotizing vasculopathies
M13_NECROVASC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2529 |
4. Check minimum number of eventsNone |
2529 |
5. Include endpoints |
2666 |
6. Filter based on genotype QC (FinnGen only) |
2666 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Aliae angiopathiae necroticantes
Similar endpoints
↥List of similar endpoints to
Other necrotizing vasculopathies
based on the number of shared cases.
Similar with more cases:
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2666 | 1567 | 1099 |
| Unadjusted period prevalence (%) | 0.51 | 0.53 | 0.48 |
| Median age at first event (years) | 65.03 | 64.45 | 65.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2360
- Matched controls
- 23600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
12.2
323.0
954
1241
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
323.0
439
*
L04AX01
ATC
azathioprine; systemic
21.2
323.0
537
323
PAW37
NOMESCO Finland
Biopsy of temporal artery
606.4
323.0
524
11
M35.3
ICD-10 Finland
Polymyalgia rheumatica
43.7
323.0
502
145
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.0
323.0
1562
5780
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
2987.4
323.0
1111
7
H02AB06
ATC
prednisolone; systemic
9.5
323.0
1948
7855
M31.6
ICD-10 Finland
Other giant cell arteritis
+∞
281.0
264
*
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
2709.8
267.7
254
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
8.4
257.7
633
990
M05BA04
ATC
alendronic acid; oral
7.1
237.0
660
1228
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
193.4
183
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.0
189.6
470
715
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.8
180.9
418
565
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
180.3
1481
7635
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
908.0
174.3
169
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
169.9
161
*
L04AA06
ATC
mycophenolic acid; systemic
26.4
168.6
238
100
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
15.9
152.3
256
179
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
151.7
144
*
A02BC02
ATC
pantoprazole; systemic
3.3
141.4
1832
12061
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
25.7
136.7
194
82
M31.7
ICD-10 Finland
Microscopic polyangiitis
1386.1
135.8
131
*
I77.6
ICD-10 Finland
Arteritis, unspecified
277.6
129.5
131
5
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
127.2
121
*
R50.9
ICD-10 Finland
Fever, unspecified
4.0
125.0
582
1773
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.1
119.1
354
666
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
117.7
112
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.3
109.2
279
425
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
108.1
103
*
H02AB07
ATC
prednisone; oral
3.6
107.2
577
1956
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
102.6
484
1464
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.5
100.4
280
480
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
99.7
95
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
97.9
516
1706
L01AA01
ATC
cyclophosphamide; systemic
43.2
95.5
119
29
ZX120
NOMESCO Finland
Intravenous
3.9
88.7
410
1205
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
9.0
83.1
183
218
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.0
82.6
182
217
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.0
81.3
211
325
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
78.7
787
3890
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
400.4
78.3
78
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
75.0
678
3150
R51.80
ICD-10 Finland
Headache
3.1
73.1
464
1722
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
71.5
72.7
83
12
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.4
70.7
281
710
C03CA01
ATC
furosemide; systemic
2.3
70.6
927
5197
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
708.8
70.4
69
*
H02AB04
ATC
methylprednisolone; systemic
2.9
70.4
503
2017
DHA10
NOMESCO Finland
Biopsy of cavity of nose
18.1
66.0
104
60
L88
ICPC
Rheumatoid/seropositive arthritis
6.2
65.0
184
317
TGC00
NOMESCO Finland
Bronchial lavation
7.4
64.2
160
231
WW400
NOMESCO Finland
Plasmaferesis
114.9
62.1
67
6
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
62.1
508
2194
A11CC03
ATC
alfacalcidol; systemic
7.5
62.0
152
214
P01BA02
ATC
hydroxychloroquine; oral
3.7
60.8
293
875
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
60.7
58
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
60.7
58
*
TPX00
NOMESCO Finland
Biopsy of artery or vein
315.6
60.6
61
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
57.5
55
*
4476A
ICD-9 Finland
Other disorders of arteries and arterioles, Arteritis, unspecified
+∞
57.5
55
*
TK800
NOMESCO Finland
Hemodialysis
7.4
57.5
142
202
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
12.9
57.1
103
83
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.4
56.3
295
940
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.9
55.6
248
691
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.9
52.4
108
114
Z94.0
ICD-10 Finland
Kidney transplant status
12.5
52.0
95
79
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.9
51.0
176
382
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
49.1
47
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.5
48.4
150
288
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
47.8
241
741
M13.9
ICD-10 Finland
Arthritis, unspecified
3.4
47.6
254
816
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.7
46.8
124
195
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
46.7
772
4576
J01MA12
ATC
levofloxacin; systemic
2.2
45.4
543
2800
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
44.9
965
6293
A12AA04
ATC
calcium carbonate; oral
7.4
44.1
108
152
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
43.9
42
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
43.2
298
1139
1XC02
NOMESCO Finland
NA
14.1
43.0
74
54
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
42.9
219
679
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
42.9
446
2145
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
42.8
41
*
J01FF01
ATC
clindamycin; systemic
2.0
42.6
700
4109
J01DB01
ATC
cefalexin; oral
2.0
42.6
1893
15773
B03XA02
ATC
darbepoetin alfa; parenteral
6.9
42.5
109
164
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
42.3
264
944
J01MA14
ATC
moxifloxacin; systemic
2.9
42.1
282
1059
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.2
41.8
169
429
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
+∞
41.8
40
*
M05BA07
ATC
risedronic acid; oral
4.2
41.4
165
413
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
40.7
139
298
AA1AD
NOMESCO Finland
CT of head and brain
2.0
39.7
671
3959
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
39.1
342
1498
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.6
38.8
70
57
A02BC01
ATC
omeprazole; systemic
1.9
38.7
738
4549
N18.0
ICD-10 Finland
End-stage renal disease
8.2
38.6
88
111
N02AX02
ATC
tramadol; systemic, rectal
1.8
38.1
1032
7155
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.9
37.6
109
193
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
37.4
282
1133
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.7
37.3
77
82
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
37.3
567
3199
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
36.5
35
*
C08CA01
ATC
amlodipine; oral
1.8
36.5
947
6448
127
Kela drug reimbursment
Transplant complication
8.0
36.2
84
109
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
36.2
303
1293
ZX108
NOMESCO Finland
Inhalation
13.2
35.7
63
49
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.6
35.3
170
502
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
35.1
299
1287
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
35.1
157
436
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
35.0
199
666
L04AD01
ATC
ciclosporin; systemic
6.9
34.6
88
131
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.7
34.4
67
64
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
33.6
253
1014
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
33.4
483
2657
R06.0
ICD-10 Finland
Dyspnoea
1.9
33.4
644
3946
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
32.8
1122
8216
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
32.5
269
1138
44698
ICD-8 Finland
Polyarteritis nodosa and allied conditions, Other
+∞
32.4
31
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
32.1
241
962
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
32.0
188
643
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.0
31.4
72
92
D69.0
ICD-10 Finland
Allergic purpura
15.2
31.4
52
35
H26.3
ICD-10 Finland
Drug-induced cataract
13.1
31.1
55
43
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
31.1
305
1406
N03AX16
ATC
pregabalin; oral
1.9
31.1
582
3512
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
+∞
30.3
29
*
J01MA02
ATC
ciprofloxacin; systemic
1.7
30.2
947
6710
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
12.5
30.0
54
44
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.9
29.8
128
343
137
Kela drug reimbursment
Uraemia requiring dialysis
9.1
29.7
63
71
A46
ICD-10 Finland
Erysipelas
2.1
29.5
385
2020
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
15.8
29.5
48
31
C07AB07
ATC
bisoprolol; oral
1.6
29.3
1180
8936
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.4
29.2
276
1248
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
29.2
28
*
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
29.2
28
*
4462A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Hypersensitivity angiitis
+∞
29.2
28
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
29.0
2003
17666
J01CA04
ATC
amoxicillin; systemic
1.7
28.9
1784
15163
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
28.7
255
1118
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
28.7
515
3052
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
28.2
212
846
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
28.2
222
911
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
28.0
458
2621
H02AB09
ATC
hydrocortisone; systemic
5.2
27.8
88
174
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
14.1
27.6
47
34
V03AE02
ATC
sevelamer; oral
14.6
27.5
46
32
4465A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Giant cell arteritis
+∞
27.1
26
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
27.0
442
2528
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
26.4
168
607
XG410
NOMESCO Finland
Flow-volume spirometry
3.4
26.3
135
419
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
26.1
25
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
26.1
25
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
25.8
217
923
WX892
NOMESCO Finland
Monitored bed care
2.5
25.8
220
943
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
25.7
821
5774
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.7
25.6
60
80
H53.1
ICD-10 Finland
Subjective visual disturbances
2.8
25.4
175
664
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
25.1
430
2491
N085, M318
ICD-10 Finland
NA
+∞
25.0
24
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
25.0
433
2520
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
10.2
24.8
49
49
ZXA00
NOMESCO Finland
Right side
1.7
24.8
674
4525
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
24.7
993
7395
L04AA01
ATC
[U] ciclosporin; systemic
6.2
24.6
67
111
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
24.5
208
888
J01AA02
ATC
doxycycline; systemic
1.6
24.5
1764
15174
WX110
NOMESCO Finland
Local anesthesy
1.6
24.3
1454
11915
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.8
24.2
69
121
4464A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Wegener's granulomatosis
+∞
24.0
23
*
M05BX04
ATC
denosumab; parenteral
2.7
23.3
162
617
V03AE01
ATC
polystyrene sulfonate; oral
5.8
23.1
66
116
UJF32
NOMESCO Finland
Coloscopy
1.7
22.9
619
4130
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
22.8
183
758
B01AA03
ATC
warfarin; systemic
1.7
22.8
529
3376
J01FA06
ATC
roxithromycin; oral
1.6
22.7
912
6744
M79.6
ICD-10 Finland
Pain in limb
1.6
22.5
792
5666
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.7
22.5
77
167
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
22.4
346
1925
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.8
22.4
98
268
1AA01
NOMESCO Finland
NA
27.6
22.2
30
11
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
22.2
611
4091
C08CA05
ATC
nifedipine; systemic
2.4
22.1
195
848
UDM02
NOMESCO Finland
Sinoscopy
4.5
22.0
79
180
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.5
21.8
103
300
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.7
21.7
97
270
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
6.0
21.6
60
102
TAB00
NOMESCO Finland
Lumbar puncture
3.0
21.6
126
430
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
21.5
811
5886
JN4AD
NOMESCO Finland
Body CT examination
2.3
21.5
205
927
J05AB11
ATC
valaciclovir; oral
2.0
21.5
315
1718
A02BC03
ATC
lansoprazole; oral
1.6
21.5
702
4915
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
16.4
21.4
34
21
R53
ICD-10 Finland
Malaise and fatigue
1.7
21.4
491
3113
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
21.3
991
7557
N03AX12
ATC
gabapentin; oral
1.9
21.3
360
2066
H57.1
ICD-10 Finland
Ocular pain
3.6
21.3
97
275
L04AA13
ATC
leflunomide; oral
3.9
21.1
88
231
B05DA
ATC
Isotonic solutions
8.8
21.1
45
52
R03AC02
ATC
salbutamol; inhalant
1.5
21.0
1118
8779
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.6
21.0
98
283
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
20.9
20
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
20.8
198
893
R4110
NOMESCO Finland
Physiotherapy
1.6
20.8
611
4152
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
20.7
150
586
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
13.0
20.7
36
28
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
8.8
20.6
44
51
B03XA01
ATC
erythropoietin; parenteral
6.8
20.3
51
76
ZXA10
NOMESCO Finland
Bilateral
1.7
20.3
458
2884
J31.0
ICD-10 Finland
Chronic rhinitis
2.3
20.0
185
826
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
19.9
239
1200
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
19.9
369
2183
N01
ICPC
Headache
2.2
19.8
212
1013
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
19.7
189
858
Z49.2
ICD-10 Finland
Other dialysis
8.1
19.7
44
55
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
19.6
230
1141
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
19.6
404
2473
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.3
19.6
99
305
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.4
19.6
40
43
JN4BD
NOMESCO Finland
Extensive body CT
2.0
19.6
279
1503
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
19.5
782
5727
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
19.4
153
627
R04.0
ICD-10 Finland
Epistaxis
2.3
19.4
192
884
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
19.4
122
438
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.6
19.3
87
245
S18
ICPC
Laceration/cut
1.5
19.0
946
7266
B05DB
ATC
Hypertonic solutions
9.2
18.9
39
43
G44.2
ICD-10 Finland
Tension-type headache
1.9
18.8
286
1576
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
18.8
18
*
WW200
NOMESCO Finland
Immunization
3.6
18.7
85
241
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
18.7
230
1167
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.9
18.4
114
405
XX9XE
NOMESCO Finland
Other ultrasound examination
8.8
18.4
39
45
J05AB01
ATC
aciclovir; systemic
1.7
18.3
458
2959
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
18.3
104
348
R04.2
ICD-10 Finland
Haemoptysis
3.0
18.3
105
355
A07AA02
ATC
nystatin; oral
2.3
18.0
177
811
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.6
18.0
63
141
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
17.9
666
4772
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
12.5
17.6
31
25
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.5
17.6
31
25
M79.1
ICD-10 Finland
Myalgia
1.9
17.5
274
1524
N05CF01
ATC
zopiclone; oral
1.5
17.5
758
5619
ZXA05
NOMESCO Finland
Left side
1.6
17.4
602
4230
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
17.4
85
256
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
10.1
17.4
34
34
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
17.4
560
3866
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.5
17.3
145
613
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.9
17.3
71
185
E0000UV
ATC
NA
1.5
17.3
840
6379
S97
ICPC
Chronic ulcer skin
2.4
17.2
145
616
A02BC05
ATC
esomeprazole; systemic
1.5
17.1
888
6835
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.8
17.0
339
2048
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.2
17.0
89
283
WX002
NOMESCO Finland
Sedation and analgesia
1.6
16.9
469
3116
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
16.8
140
592
B02.9
ICD-10 Finland
Zoster without complication
2.3
16.8
157
704
M31.2
ICD-10 Finland
Lethal midline granuloma
+∞
16.7
16
*
UKC02
NOMESCO Finland
Cystoscopy
1.7
16.7
382
2405
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
9.3
16.6
34
37
N19
ICD-10 Finland
Unspecified kidney failure
2.9
16.6
103
367
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.9
16.6
68
177
A03
ICPC
Fever
1.8
16.6
302
1769
H65.2
ICD-10 Finland
Chronic serous otitis media
5.3
16.5
50
96
L95.8
ICD-10 Finland
Other vasculitis limited to skin
18.0
16.5
25
14
M04AA01
ATC
allopurinol; systemic
1.8
16.3
310
1842
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
16.3
218
1141
R05
ICD-10 Finland
Cough
1.6
16.0
418
2723
M25.5
ICD-10 Finland
Pain in joint
1.5
15.9
582
4130
M05BA06
ATC
ibandronic acid; systemic
3.5
15.9
74
215
XCK00
NOMESCO Finland
Perimetry
2.2
15.9
175
847
A02BA02
ATC
ranitidine; systemic
1.6
15.9
470
3170
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.7
15.9
54
118
L17
ICPC
Foot/toe symptom/complaint
1.5
15.8
566
4000
N02AA05
ATC
oxycodone; systemic
1.7
15.8
350
2179
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.4
15.8
78
238
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.7
15.5
67
183
J02AC01
ATC
fluconazole; systemic
1.5
15.5
790
6027
NHQ40
NOMESCO Finland
Amputation of toe
4.0
15.5
62
159
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
9.0
15.4
32
36
TK820
NOMESCO Finland
Peritoneal dialysis
9.5
15.4
31
33
5BA08
NOMESCO Finland
NA
9.5
15.4
31
33
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
15.4
267
1539
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
15.3
161
761
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.3
15.3
143
640
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
5.4
15.3
45
84
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
15.2
168
814
196
Kela drug reimbursment
Paricalcitol and cinacalcet
9.2
15.2
31
34
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
6.0
15.1
41
69
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
15.1
422
2796
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
15.1
429
2860
M05.2
ICD-10 Finland
Rheumatoid vasculitis
45.3
15.1
18
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
15.1
684
5086
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
15.1
157
741
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
15.0
337
2101
V03AE03
ATC
lanthanum carbonate; oral
11.9
15.0
27
23
H15.1
ICD-10 Finland
Episcleritis
4.8
15.0
50
107
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
15.0
180
904
I50.9
ICD-10 Finland
Heart failure, unspecified
1.7
14.9
344
2164
TK810
NOMESCO Finland
Hemofiltration
7.6
14.9
34
45
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.9
14.9
61
160
A01
ICPC
Pain general/multiple sites
2.0
14.7
190
983
205
Kela drug reimbursment
Chronic hypertension
1.5
14.6
691
5173
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
14.6
181
920
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
+∞
14.6
14
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
14.6
76
242
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.5
14.6
116
480
RS221
NOMESCO Finland
NA
4.5
14.4
50
112
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.7
14.4
98
372
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.2
14.3
76
245
H26.4
ICD-10 Finland
After-cataract
1.8
14.3
239
1360
SPAT1153
SPAT
Removal of sutures
1.5
14.3
703
5303
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
14.2
158
767
H53.2
ICD-10 Finland
Diplopia
2.9
14.1
86
303
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
14.1
598
4374
R01AD08
ATC
fluticasone; nasal
1.5
14.0
561
4052
R60.0
ICD-10 Finland
Localized oedema
1.8
13.9
260
1533
SPAT1263
SPAT
Sampling
1.4
13.9
909
7236
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
13.9
178
918
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
13.9
352
2272
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
13.8
313
1955
RD210
NOMESCO Finland
NA
4.5
13.8
48
108
R51.81
ICD-10 Finland
Facial pain NOS
3.5
13.8
64
187
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
13.7
135
619
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.4
13.7
65
193
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
5.9
13.6
37
63
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
13.6
173
888
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
13.5
175
907
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.7
13.4
92
350
1CX01
NOMESCO Finland
NA
21.3
13.3
19
9
NXL00
NOMESCO Finland
Biopsy of muscle
11.5
13.3
24
21
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.2
716
5486
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
13.2
810
6358
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.3
13.2
121
538
J01FA10
ATC
azithromycin; systemic
1.4
13.1
1131
9419
L28
ICPC
Limited function/disability (L)
1.6
13.1
370
2454
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
13.1
261
1568
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.6
13.0
59
169
L04AC07
ATC
tocilizumab; parenteral
16.8
13.0
20
12
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
12.9
373
2486
3AC01
NOMESCO Finland
NA
5.1
12.9
40
80
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
12.8
248
1478
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
12.8
113
494
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
8.5
12.7
27
32
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
11.0
12.5
23
21
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.7
12.5
83
311
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
10.1
12.5
24
24
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.3
12.5
29
40
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
12.4
224
1306
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.8
12.4
40
84
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
12.4
1344
11590
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
12.3
55
156
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
12.3
281
1759
H34.1
ICD-10 Finland
Central retinal artery occlusion
7.1
12.3
29
41
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.2
12.3
32
52
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
12.3
530
3872
N25.0
ICD-10 Finland
Renal osteodystrophy
10.5
12.2
23
22
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
12.2
175
941
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
9.0
12.2
25
28
R51
ICD-10 Finland
Headache
2.3
12.2
110
488
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
12.1
321
2090
A04
ICPC
Weakness/tiredness general
1.7
12.1
284
1789
GD1UN
NOMESCO Finland
Lung circulation SPECT
7.8
12.1
27
35
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
12.1
164
866
Z71.8
ICD-10 Finland
Other specified counselling
1.5
12.1
450
3182
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
11.1
12.0
22
20
C09AA02
ATC
enalapril; systemic
1.5
12.0
460
3274
M81.4
ICD-10 Finland
Drug-induced osteoporosis
9.3
12.0
24
26
321
Kela drug reimbursment
Paricalcitol and cinacalcet
6.3
12.0
31
50
R03DC03
ATC
montelukast; oral
1.6
12.0
312
2026
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
46.9
11.9
14
*
J01DA01
ATC
[U] cefalexin; systemic
1.4
11.9
1331
11502
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.9
11.8
73
260
R4190
NOMESCO Finland
Nutritional therapy
2.8
11.8
76
280
B01AB05
ATC
enoxaparin; parenteral
1.4
11.8
655
5023
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
10.6
11.7
22
21
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.4
11.7
55
163
C08CA02
ATC
felodipine; oral
1.7
11.7
235
1418
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
11.6
307
1997
H15.0
ICD-10 Finland
Scleritis
11.1
11.5
21
19
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
11.5
478
3457
R01AD09
ATC
mometasone; nasal
1.4
11.5
855
6897
B01AC04
ATC
clopidogrel; oral
1.6
11.5
365
2486
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
11.5
11
*
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
+∞
11.5
11
*
M13.0
ICD-10 Finland
Polyarthritis, unspecified
4.5
11.4
39
87
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
11.4
718
5626
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
11.4
146
752
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
11.4
300
1953
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.3
11.4
109
495
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
11.3
90
374
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
11.9
11.3
20
17
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
11.2
195
1124
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
11.1
262
1652
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
11.1
228
1380
XPX04
NOMESCO Finland
Angioscopy
25.1
11.1
15
6
SPAT1255
SPAT
Intravenous administration of medicine
1.9
11.1
153
813
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
11.1
361
2470
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.3
11.1
54
165
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
8.1
11.1
24
30
6BA02
NOMESCO Finland
NA
11.2
11.0
20
18
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
7.1
11.0
26
37
N06AA09
ATC
amitriptyline; systemic
1.7
11.0
224
1356
SPAT1301
SPAT
No procedures
1.4
11.0
693
5421
B01AF02
ATC
apixaban; oral
1.7
11.0
235
1442
G50.1
ICD-10 Finland
Atypical facial pain
3.4
10.9
51
151
L95
ICPC
Osteoporosis
2.5
10.9
86
354
H53.4
ICD-10 Finland
Visual field defects
3.0
10.9
60
201
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
10.9
351
2397
R03BB04
ATC
tiotropium bromide; inhalant
1.7
10.8
222
1344
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
12.0
10.8
19
16
SPAT1262
SPAT
Handing over of treatment supplies
1.5
10.8
395
2779
B07.9
ICD-10 Finland
Verruca simplex
2.7
10.8
73
278
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
10.8
111
524
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
10.8
408
2890
D68.8
ICD-10 Finland
Other specified coagulation defects
5.1
10.8
33
66
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
10.8
231
1418
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
10.7
531
3971
I73.0
ICD-10 Finland
Raynaud syndrome
4.7
10.7
35
75
J47
ICD-10 Finland
Bronchiectasis
3.2
10.7
55
176
XF402
NOMESCO Finland
ECG with work load test
1.7
10.7
245
1537
M54.5
ICD-10 Finland
Low back pain
1.4
10.6
620
4778
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.1
10.6
58
193
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
10.6
230
1416
R02
ICPC
Shortness of breath/dyspnoea
1.6
10.6
263
1681
D07AC01
ATC
betamethasone; topical
1.4
10.6
690
5423
N17.8
ICD-10 Finland
Other acute renal failure
4.1
10.6
40
99
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
6.3
10.6
27
43
H47.1
ICD-10 Finland
Papilloedema, unspecified
7.0
10.6
25
36
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
10.5
167
933
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.5
148
794
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.6
10.5
26
40
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
7.3
10.5
24
33
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.7
10.4
200
1187
4AC07
NOMESCO Finland
NA
110.5
10.4
11
*
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
10.4
10
*
PAA99
NOMESCO Finland
Exploration of other arterial branch originating from aortic arch arteries
+∞
10.4
10
*
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
10.4
10
*
4AC0X
NOMESCO Finland
NA
+∞
10.4
10
*
M79.7
ICD-10 Finland
Fibromyalgia
2.8
10.4
63
225
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
10.4
128
650
WZC30
NOMESCO Finland
Teaching
1.6
10.4
276
1797
EB1WA
NOMESCO Finland
NA
6.8
10.4
25
37
N30.0
ICD-10 Finland
Acute cystitis
1.6
10.4
307
2057
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.5
10.3
81
336
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.5
10.3
77
311
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
10.3
491
3644
R80
ICD-10 Finland
Isolated proteinuria
5.5
10.3
29
53
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.0
10.2
56
187
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
9.6
10.2
20
21
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
9.6
10.2
20
21
A01AB10
ATC
natamycin; local oral
2.7
10.2
70
269
TNG10
NOMESCO Finland
Puncture of knee
4.3
10.2
36
84
J01CF05
ATC
flucloxacillin; systemic
2.4
10.2
85
363
318
Kela drug reimbursment
Teriparatide
6.2
10.1
26
42
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.8
10.1
160
893
J01FA09
ATC
clarithromycin; systemic
1.4
10.1
609
4714
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.1
10.0
26
43
N00.9
ICD-10 Finland
Acute nephritic syndrome, Unspecified
40.2
10.0
12
*
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
40.2
10.0
12
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
9.9
98
455
XW000
NOMESCO Finland
Bone marrow biopsy
2.2
9.9
97
448
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.3
9.9
92
416
DC1AD
NOMESCO Finland
Temporalbone CT
4.6
9.9
33
73
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
9.9
126
650
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.0
9.8
118
596
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.1
9.8
111
547
D638, N188
ICD-10 Finland
NA
26.1
9.8
13
5
C09CA01
ATC
losartan; oral
1.4
9.8
520
3932
E000001
ATC
NA
1.5
9.7
401
2887
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
9.7
522
3958
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
9.7
224
1408
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.6
9.6
27
49
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.6
9.6
42
119
J45.8
ICD-10 Finland
Mixed asthma
2.5
9.6
72
291
SPAT1254
SPAT
Administration of medicine
1.5
9.6
328
2268
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
9.5
208
1283
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.4
9.5
81
350
B01AB10
ATC
tinzaparin; parenteral
1.8
9.5
157
891
M05BA01
ATC
etidronic acid; systemic
5.4
9.5
27
50
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.7
9.5
26
46
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.9
9.5
55
191
N03.7
ICD-10 Finland
Chronic nephritic syndrome, diffuse crescentic glomerulonephritis
100.4
9.4
10
*
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
100.4
9.4
10
*
R4120
NOMESCO Finland
Occupational therapy
1.9
9.4
127
671
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
3.7
9.4
39
106
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
17.6
9.4
14
8
N085M
ICD-10 Finland
NA
+∞
9.4
9
*
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
5.3
9.4
27
51
C10AA05
ATC
atorvastatin; oral
1.3
9.3
836
6890
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.9
9.3
142
786
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.7
9.3
17
16
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.3
636
5021
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.9
9.3
126
668
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
9.2
157
899
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
9.2
242
1573
PD5AD
NOMESCO Finland
CT of aorta
3.6
9.1
40
114
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
5.0
9.1
28
57
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.1
9.0
47
153
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.7
9.0
59
223
R05
ICPC
Cough
1.4
9.0
429
3177
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
9.0
68
277
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
8.9
86
396
L95.0
ICD-10 Finland
Livedoid vasculitis
24.1
8.9
12
5
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.9
8.8
51
177
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
8.8
136
755
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
8.8
171
1021
H05BX01
ATC
cinacalcet; oral
5.1
8.8
26
51
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
9.5
8.8
17
18
UJF92
NOMESCO Finland
Capsular endoscopy
3.0
8.8
48
162
L18
ICPC
Muscle pain
2.3
8.7
76
333
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
8.7
105
531
B34.9
ICD-10 Finland
Viral infection, unspecified
2.8
8.7
55
201
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.8
8.7
35
93
A01AB09
ATC
miconazole; local oral
1.6
8.7
200
1256
M48.0
ICD-10 Finland
Spinal stenosis
1.6
8.7
256
1710
R01AD12
ATC
fluticasone furoate; nasal
1.4
8.6
510
3920
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.5
8.6
38
109
C08CA13
ATC
lercanidipine; oral
1.5
8.6
303
2107
UDC00
NOMESCO Finland
Ear microscopy
1.8
8.6
151
875
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
8.6
149
861
H05AA02
ATC
teriparatide; parenteral
5.8
8.6
23
40
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
8.6
596
4705
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.9
8.6
50
175
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
8.6
1336
11842
M35.7
ICD-10 Finland
Hypermobility syndrome
16.3
8.5
13
8
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
9.0
8.5
17
19
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.1
8.5
90
433
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
5.1
8.5
25
49
ZZA00
NOMESCO Finland
Split skin graft
2.3
8.4
72
314
R31
ICD-10 Finland
Unspecified haematuria
1.6
8.4
210
1345
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
8.4
94
463
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
8.4
279
1914
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.5
8.4
37
107
4466A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Thrombotic microangiopathy
+∞
8.3
8
*
4AC0L
NOMESCO Finland
NA
+∞
8.3
8
*
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.3
261
1769
CS494
NOMESCO Finland
Other visual field testing
2.6
8.3
57
221
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.5
8.3
37
108
SPAT1325
SPAT
Vaccination
1.3
8.3
747
6133
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
4.0
8.2
31
78
L88
ICD-10 Finland
Pyoderma gangrenosum
14.5
8.2
13
9
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
14.5
8.2
13
9
J37.0
ICD-10 Finland
Chronic laryngitis
2.4
8.2
67
286
I15.0
ICD-10 Finland
Renovascular hypertension
6.5
8.2
20
31
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
5.1
8.2
24
47
R03BA05
ATC
fluticasone; inhalant
1.5
8.2
341
2459
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
8.1
260
1773
A06AD11
ATC
lactulose; oral
1.5
8.1
314
2229
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
8.1
89
436
3025
Kela drug reimbursment
Calcium carbonate
8.9
8.0
16
18
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.7
8.0
53
202
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
10.1
8.0
15
15
WX722
NOMESCO Finland
PEEP
2.0
8.0
102
529
A01AB04
ATC
amphotericin B; local oral
1.9
8.0
114
617
R63.4
ICD-10 Finland
Abnormal weight loss
2.2
8.0
81
381
H34.2
ICD-10 Finland
Other retinal artery occlusions
5.9
8.0
21
36
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
8.0
1029
8859
R55
ICD-10 Finland
Syncope and collapse
1.5
8.0
238
1593
R01AD01
ATC
beclometasone; nasal
1.5
7.9
281
1956
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.7
7.9
51
190
L99
ICPC
Musculoskeletal disease other
2.8
7.9
48
174
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.2
7.9
28
67
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
7.8
7.9
17
22
I50.0
ICD-10 Finland
Congestive heart failure
1.7
7.9
163
995
G47.3
ICD-10 Finland
Sleep apnoea
1.4
7.9
379
2806
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.9
7.8
30
77
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.9
7.8
30
77
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.8
247
1675
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
7.8
90
449
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.1
7.8
41
135
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.8
7.8
31
82
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.3
7.8
68
300
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
5.4
7.8
22
41
RS222
NOMESCO Finland
NA
3.4
7.8
36
108
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
7.8
78
367
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.5
7.8
59
243
DFF00
NOMESCO Finland
Pure tone audiometry
1.6
7.8
185
1172
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
9.4
7.8
15
16
R52.2
ICD-10 Finland
Other chronic pain
2.2
7.8
72
326
H46
ICD-10 Finland
Optic neuritis
4.8
7.8
24
50
TQW80
NOMESCO Finland
Local dermatologic skincare
2.5
7.7
60
247
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
7.7
552
4369
XQ800
NOMESCO Finland
Prick test
1.8
7.7
121
675
GBA32
NOMESCO Finland
Endoscopic dilatation of trachea
45.1
7.7
9
*
N05.8
ICD-10 Finland
Unspecified nephritic syndrome, other
45.1
7.7
9
*
J38.6
ICD-10 Finland
Stenosis of larynx
45.1
7.7
9
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.7
7.7
51
195
D07AB08
ATC
desonide; topical
1.6
7.7
207
1352
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.4
7.7
35
104
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.8
7.6
46
166
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
7.6
169
1051
XX9XW
NOMESCO Finland
NA
4.7
7.6
24
51
WZA90
NOMESCO Finland
Other doctors statement
1.4
7.6
423
3210
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.6
359
2646
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.5
7.6
56
225
Z99.2
ICD-10 Finland
Dependence on renal dialysis
18.4
7.6
11
6
J20
ICD-10 Finland
Acute bronchitis
1.6
7.6
181
1145
R52.9
ICD-10 Finland
Pain, unspecified
1.7
7.6
171
1066
M70.2
ICD-10 Finland
Olecranon bursitis
2.3
7.6
65
284
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.8
7.5
30
80
ED1AA
NOMESCO Finland
Mandipular X-ray examination
5.4
7.5
21
39
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.7
7.5
48
178
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.3
7.5
68
306
L93.0
ICD-10 Finland
Discoid lupus erythematosus
7.1
7.5
17
24
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.5
1023
8851
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.7
7.4
49
187
R11
ICD-10 Finland
Nausea and vomiting
1.7
7.4
159
980
R13
ICD-10 Finland
Dysphagia
1.7
7.4
135
793
C10AA01
ATC
simvastatin; oral
1.3
7.4
973
8374
R03AK08
ATC
formoterol and beclometasone; inhalant
2.2
7.4
72
334
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
7.4
199
1299
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.4
617
4995
A12BA01
ATC
potassium chloride; oral
1.8
7.4
118
662
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.0
7.4
39
130
A99
ICPC
Disease/condition unspecnature/site
1.7
7.4
155
951
R42
ICD-10 Finland
Dizziness and giddiness
1.4
7.4
464
3597
XF404
NOMESCO Finland
Ambulatory ECG
1.6
7.3
189
1223
R06AE07
ATC
cetirizine; oral
1.3
7.3
813
6845
4467A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Takayasu's disease
+∞
7.3
7
*
M35.2
ICD-10 Finland
Behçet disease
+∞
7.3
7
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
10.9
7.3
13
12
Z00.0
ICD-10 Finland
General medical examination
1.4
7.3
357
2652
R03BA08
ATC
ciclesonide; inhalant
1.7
7.3
147
890
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.1
7.2
76
366
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
7.2
199
1311
E000006
ATC
NA
1.7
7.2
150
917
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.0
7.2
91
471
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.3
7.2
16
22
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.9
7.2
107
589
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
30.1
7.1
9
*
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
20.1
7.1
10
5
AN1
HP
Coronary angiography
1.5
7.1
257
1795
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.1
243
1679
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
7.1
448
3471
NGQ20
NOMESCO Finland
Amputation of lower leg
5.0
7.1
21
42
M01AH02
ATC
rofecoxib; oral
1.5
7.1
273
1933
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
12.1
7.1
12
10
M86.8
ICD-10 Finland
Other osteomyelitis
12.1
7.1
12
10
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
4.5
7.1
23
51
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
7.1
174
1112
RS220
NOMESCO Finland
NA
3.4
7.0
32
96
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.6
7.0
49
192
F29
ICPC
Eye symptom/complaint other
1.6
7.0
158
988
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.1
7.0
36
118
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
7.0
273
1941
H25.0
ICD-10 Finland
Senile incipient cataract
1.7
6.9
132
785
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.1
6.9
76
372
C02AC05
ATC
moxonidine; oral
1.9
6.9
99
537
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.9
311
2271
R81
ICPC
Pneumonia
2.1
6.9
73
351
R33
ICD-10 Finland
Retention of urine
1.6
6.9
158
992
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
2.5
6.8
52
215
J32.4
ICD-10 Finland
Chronic pansinusitis
3.1
6.8
34
109
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
6.8
156
978
NFQ20
NOMESCO Finland
Amputation of femur
4.0
6.8
25
63
K07.60
ICD-10 Finland
Snapping jaw
2.0
6.8
77
383
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
6.7
122
717
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
6.7
137
831
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
16.7
6.7
10
6
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.3
6.7
31
94
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.2
6.7
33
105
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.7
748
6280
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
6.7
153
957
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.2
6.7
62
281
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.1
6.7
70
337
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.9
6.7
37
128
45100
ICD-8 Finland
Phlebitis and thrombophlebitis, Of lower extremities
3.6
6.7
28
79
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.6
6.7
44
169
SPAT1310
SPAT
Counselling related to known health issue
1.3
6.7
631
5188
H92.0
ICD-10 Finland
Otalgia
1.9
6.6
91
487
G45.3
ICD-10 Finland
Amaurosis fugax
2.5
6.6
47
187
D72.1
ICD-10 Finland
Eosinophilia
6.4
6.6
16
25
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.3
6.6
57
252
DPA30
NOMESCO Finland
Sphenotomy
5.2
6.6
19
37
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.2
6.6
65
306
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
7.8
6.6
14
18
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
6.6
28
80
RJ412
NOMESCO Finland
NA
12.3
6.6
11
9
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
12.3
6.6
11
9
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.7
6.6
26
70
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
3.7
6.6
26
70
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.9
6.6
38
134
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.9
6.6
38
134
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.1
6.5
69
334
K65.0
ICD-10 Finland
Acute peritonitis
3.0
6.5
34
113
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
4.5
6.5
21
47
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.7
6.5
42
159
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.3
6.5
30
92
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.3
6.5
30
92
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.1
6.5
32
103
K05.30
ICD-10 Finland
Periodontitis complex
1.5
6.4
232
1621
L14
ICPC
Leg/thigh symptom/complaint
1.6
6.4
144
898
C02KX01
ATC
bosentan; oral
70.0
6.4
7
*
N01.7
ICD-10 Finland
Rapidly progressive nephritic syndrome, diffuse crescentic glomerulonephritis
70.0
6.4
7
*
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.4
470
3724
KH1EE
NOMESCO Finland
Urologic ultrasound examination
7.4
6.4
14
19
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
6.4
122
729
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.9
6.4
93
511
S19
ICPC
Skin injury other
2.0
6.4
79
410
S29
ICPC
Skin symptom/complaint other
1.4
6.3
322
2404
C09CA06
ATC
candesartan; oral
1.3
6.3
416
3242
C02CA01
ATC
prazosin; oral
2.7
6.3
41
155
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
6.3
96
534
DHB10
NOMESCO Finland
Excision of lesion of internal nose
6.0
6.3
16
27
A08
ICPC
Swelling
1.9
6.3
86
459
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
5.5
6.3
17
31
DJA10
NOMESCO Finland
Biopsy of septum of nose
11.0
6.3
11
10
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
11.0
6.3
11
10
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.3
1171
10431
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.4
6.3
48
199
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
9.3
6.3
12
13
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.7
6.3
25
68
K05.1
ICD-10 Finland
Chronic gingivitis
1.7
6.3
119
709
I77.9
ICD-10 Finland
Disorder of arteries and arterioles, unspecified
18.1
6.3
9
5
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
6.3
107
619
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.1
6.3
31
100
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
6.3
191
1286
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.7
6.3
124
748
M33.2
ICD-10 Finland
Polymyositis
+∞
6.3
6
*
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
6.3
6
*
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
6.3
6
*
N085, M319
ICD-10 Finland
NA
+∞
6.3
6
*
7250A
ICD-9 Finland
Polymyalgia rheumatica[POLYMYALGIA RHEUMATICA]
+∞
6.3
6
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
6.3
6
*
N00.7
ICD-10 Finland
Acute nephritic syndrome, Diffuse crescentic glomerulonephritis
+∞
6.3
6
*
M31
ICD-10 Finland
Other necrotizing vasculopathies
+∞
6.3
6
*
N00.8
ICD-10 Finland
Acute nephritic syndrome, Other
+∞
6.3
6
*
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.9
6.2
34
117
SBB10
NOMESCO Finland
Teeth copy
1.8
6.2
99
557
I67.7
ICD-10 Finland
Cerebral arteritis, not elsewhere classified
26.7
6.2
8
*
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
26.7
6.2
8
*
U14
ICPC
Kidney symptom/complaint
2.9
6.2
36
127
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
3.4
6.2
27
79
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
4.1
6.2
22
54
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.1
6.2
22
54
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
4.1
6.2
22
54
M10.3
ICD-10 Finland
Gout due to impairment of renal function
6.3
6.2
15
24
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.4
6.1
47
195
I20.09
ICD-10 Finland
Unstable angina
1.7
6.1
128
784
D638, N189
ICD-10 Finland
NA
12.5
6.1
10
8
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.1
494
3971
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
6.1
90
495
C01AA05
ATC
digoxin; systemic
1.5
6.1
183
1231
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.0
6.1
76
394
M03BX02
ATC
tizanidine; oral
1.2
6.1
1159
10339
M01AH03
ATC
valdecoxib; oral
1.7
6.0
129
797
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
6.0
241
1722
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
6.0
174
1159
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.4
6.0
20
46
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
3.4
6.0
27
81
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
6.7
6.0
14
21
C07AB02
ATC
metoprolol; systemic
1.3
6.0
455
3616
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
10.0
6.0
11
11
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.0
6.0
11
11
L01BB01
ATC
NA
10.0
6.0
11
11
S22.3
ICD-10 Finland
Fracture of rib
1.7
6.0
122
743
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.4
6.0
26
76
B35.3
ICD-10 Finland
Tinea pedis
2.0
6.0
74
383
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001604) Monocytes [#/volume] in Blood
2065
10559
5.24
308.88
15.6
5.4
e9/l
0.6
0.6
9.81
1929
9021
(3006315) Basophils [#/volume] in Blood
2069
10597
5.25
308.76
15.6
5.4
e9/l
0.0
0.0
0.11
1931
9070
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
489
468
12.57
307.65
2.7
1.2
g/l
0.2
0.2
0.58
465
441
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
461
565
9.66
307.65
1.7
1.6
iu/ml
0.5
11.5
0.55
97
118
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
492
488
12.14
307.65
2.7
1.2
g/l
1.2
1.2
0.05
469
458
(3037522) Nuclear Ab [Titer] in Serum
1035
2436
6.31
307.65
1.7
1.3
titre
612.3
420.5
2.27
266
476
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
778
621
17.28
307.65
3.6
1.4
titre
328.8
236.5
0.34
112
23
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
397
310
14.87
307.65
5.5
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
735
1484
6.46
307.65
5.1
2.6
g/l
9.3
10.6
8.90
701
1339
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1045
805
20.71
307.65
6.7
1.2
u/ml
21.6
8.5
—
257
7
(3013115) Eosinophils [#/volume] in Blood
2093
10972
5.22
298.57
16.1
5.6
e9/l
0.2
0.2
11.03
1962
9517
(3019198) Lymphocytes [#/volume] in Blood
2079
10847
5.16
298.32
15.7
5.5
e9/l
1.8
1.9
2.93
1955
9453
(42870588) Differential panel, method unspecified - Blood
1633
7345
4.16
282.72
14.1
5.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1916
9669
4.49
280.43
16.1
5.6
%
0.6
0.7
5.34
1875
8966
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
381
499
8.74
279.61
3.1
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1945
9986
4.50
276.15
16.4
5.9
%
8.6
8.8
1.84
1905
9280
(3006504) Eosinophils/100 leukocytes in Blood
1932
9941
4.43
271.66
16.2
5.6
%
2.3
2.8
27.49
1893
9204
(3018010) Neutrophils/100 leukocytes in Blood
1932
10056
4.35
264.27
15.7
5.5
%
62.3
57.7
51.91
1887
9342
(3002030) Lymphocytes/100 leukocytes in Blood
1948
10230
4.36
262.24
16.3
5.7
%
23.8
27.1
37.60
1906
9466
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
230
171
14.63
249.19
3.7
1.1
u/ml
42.6
—
—
5
0
(3028026) IgM [Mass/volume] in Serum or Plasma
544
1166
5.61
247.32
2.0
1.8
g/l
1.0
1.4
4.94
507
1046
(3015171) Extractable nuclear Ab [Units/volume] in Serum
386
640
6.88
228.23
1.5
1.2
u/ml
0.6
0.7
0.11
31
59
(3013650) Neutrophils [#/volume] in Blood by Automated count
2122
12493
4.42
226.90
18.2
8.7
e9/l
4.9
4.2
33.92
1986
10833
(3004588) Protein electrophoresis panel - Serum or Plasma
606
1572
4.69
218.00
1.7
2.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
149
58
27.15
216.58
1.6
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1988
11497
3.87
210.81
13.9
6.7
mmol/l
1.2
1.2
1.25
1739
9640
(3017143) Hepatitis C virus Ab [Presence] in Serum
676
1967
4.26
208.55
2.0
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1719
9136
3.48
207.33
3.4
2.2
nmol/l
80.7
78.7
2.35
1631
8031
(3020630) Protein [Mass/volume] in Serum or Plasma
656
1917
4.21
200.54
1.8
2.8
g/l
64.5
66.3
5.78
599
1732
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
285
393
8.00
198.61
5.4
4.8
iu/ml
556.8
853.0
0.33
42
53
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1825
10455
3.36
186.15
11.6
6.0
mmol/l
1.2
1.2
0.55
1765
9374
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
709
2311
3.82
184.21
2.0
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
597
1785
4.02
174.87
7.6
3.9
%
0.9
0.8
0.04
242
530
(3023368) Bacteria identified in Blood by Culture
1319
6450
3.07
174.00
5.9
4.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
649
2069
3.82
173.22
13.9
7.1
mmol/l
11.4
10.4
2.86
635
1968
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
233
301
8.39
171.14
3.1
2.7
u/ml
54613.3
2494.8
—
10
23
(3021879) Hepatitis B virus core Ab [Presence] in Serum
482
1250
4.49
170.84
1.4
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
810
3010
3.43
170.51
13.3
5.5
mmol/l
1.1
1.0
6.07
779
2774
(3021440) Promyelocytes/100 leukocytes in Blood
571
1688
4.03
169.56
7.8
3.9
%
0.2
0.1
0.34
230
483
(3002179) Metamyelocytes/100 leukocytes in Blood
555
1627
4.05
166.54
7.2
3.7
%
0.5
0.6
1.27
183
371
(3024980) IgG subclass 4 [Mass/volume] in Serum
222
280
8.56
166.24
1.7
1.5
g/l
0.7
0.8
0.56
163
219
(46235355) HIV 1 and 2 tests - Meaningful Use set
750
2700
3.47
165.51
2.0
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
167
145
12.22
163.96
1.7
1.1
titre
275.7
137.0
0.92
44
20
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
376
834
5.08
161.19
1.6
1.8
u/l
33.1
38.8
7.04
343
722
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
228
312
7.90
159.31
1.5
1.1
u/ml
2.0
7.0
0.47
20
15
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
249
386
7.01
155.45
1.6
1.1
u/ml
5.3
4.0
0.29
39
24
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
261
429
6.64
154.06
1.5
1.1
u/ml
32.2
8.9
0.87
16
16
(3036481) Cortisol [Moles/volume] in Serum or Plasma
591
1907
3.70
153.37
2.3
2.1
nmol/l
341.9
376.6
2.88
550
1722
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
250
395
6.88
153.26
1.6
1.1
u/ml
16.0
4.8
1.35
57
49
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
720
2664
3.33
150.41
3.9
4.2
u/l
248.0
249.5
0.08
685
2515
(3018418) pH of Serum or Plasma
1321
6854
2.84
150.04
8.5
3.9
ph
7.4
7.4
0.05
266
1304
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
784
3070
3.20
148.77
4.6
2.6
%
21.6
22.2
0.62
687
2615
(3025159) Blasts/100 leukocytes in Blood
521
1579
3.86
147.91
8.1
3.9
%
0.0
0.3
0.57
200
407
(3022948) Iron [Moles/volume] in Serum or Plasma
849
3531
3.06
144.51
4.3
2.5
umol/l
11.5
12.6
4.36
806
3262
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1306
6863
2.77
142.75
2.7
2.1
u/l
122.6
224.8
6.85
1244
6389
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
271
501
5.91
141.77
1.7
2.0
mg/l
11.4
11.9
0.41
248
456
(3004789) Transferrin [Mass/volume] in Serum or Plasma
804
3287
3.07
140.53
4.4
2.5
g/l
2.2
2.3
9.95
761
3031
(3013707) Erythrocyte sedimentation rate by Westergren method
2275
16137
3.79
139.86
14.9
3.8
mm/h
17.2
13.4
20.40
2210
14776
(3018095) Leukocytes [#/volume] in Urine
1423
7877
2.73
139.26
9.0
3.7
e6/l
66.1
123.6
2.59
1160
5661
(3002582) Erythrocytes [#/volume] in Urine
1287
6804
2.72
137.63
7.6
3.2
e6/l
32.5
74.6
3.41
1127
5261
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
794
3277
3.03
135.85
1.4
1.2
iu/ml
34.0
38.1
0.39
269
998
(3024139) IgG subclass 3 [Mass/volume] in Serum
159
170
9.88
135.05
1.4
1.4
g/l
0.3
0.4
0.92
114
124
(3028192) IgG subclass 2 [Mass/volume] in Serum
159
170
9.88
135.05
1.4
1.4
g/l
2.5
2.9
1.08
116
125
(3027135) IgG subclass 1 [Mass/volume] in Serum
159
170
9.88
135.05
1.4
1.4
g/l
6.2
7.0
1.25
116
124
(3000850) Epithelial cells [#/volume] in Urine
1014
4787
2.80
134.93
5.6
2.6
e6/l
4.2
5.8
4.20
942
4191
(3037467) Urinalysis macro (dipstick) panel - Urine
2171
15180
3.32
131.96
10.8
4.4
—
—
—
0
0
(4062490)
158
174
9.59
131.24
1.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1707
10561
2.71
130.19
7.3
3.8
estimate
0.0
0.0
0.00
397
1929
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
400
1097
4.11
129.82
3.1
1.7
g/l
1.8
1.5
5.03
347
943
(3009261) Glucose [Presence] in Urine by Test strip
1719
10732
2.69
127.67
7.4
3.9
estimate
0.0
0.0
1.08
406
1895
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
538
1830
3.43
126.81
8.1
3.7
ng/l
118.9
92.4
4.69
506
1551
(3021601) Nitrite [Presence] in Urine by Test strip
1700
10599
2.67
125.86
9.8
5.2
estimate
0.0
0.0
0.50
412
1942
(36304419) Bacteria [Presence] in Urine
1159
6040
2.63
124.37
7.1
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
751
3145
2.93
123.63
1.3
1.2
u/ml
10.0
14.4
0.92
257
1159
(3030467) Casts [#/volume] in Urine by Automated count
1183
6243
2.61
123.46
7.5
3.1
e6/l
0.3
0.5
6.95
1019
4760
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
346
894
4.30
121.35
1.6
2.6
g/l
3.8
3.8
0.11
252
643
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
346
895
4.29
121.16
1.6
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
346
896
4.29
120.98
1.6
2.6
g/l
8.4
7.4
12.08
259
673
(3026782) Osmolality of Urine
940
4514
2.67
117.97
5.9
2.7
mosm/kgh2o
516.9
544.1
4.11
847
3825
(3024561) Albumin [Mass/volume] in Serum or Plasma
1602
9989
2.51
113.93
8.3
4.7
g/l
33.7
35.1
16.93
1533
9263
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
843
3896
2.70
113.53
2.3
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
662
2712
2.92
112.21
3.7
2.5
%
1.9
1.8
1.62
614
2386
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
322
840
4.22
111.16
1.6
2.6
g/l
9.7
10.4
1.96
278
710
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
321
836
4.23
111.06
1.7
2.6
g/l
3.7
3.1
13.28
254
660
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2283
17146
3.31
108.23
16.0
7.4
u/l
73.9
79.6
10.52
2244
16042
(3021589) Normoblasts [#/volume] in Blood
1521
9427
2.43
107.09
21.0
9.6
e9/l
0.0
0.0
0.15
1350
7651
(3007164) IgA [Mass/volume] in Serum or Plasma
814
3790
2.65
107.04
1.8
1.4
g/l
2.3
2.5
2.70
608
2197
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
275
663
4.51
105.05
1.7
2.6
g/l
0.0
0.0
0.65
254
608
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
294
748
4.29
104.74
1.8
3.5
ratio
1.6
1.6
0.02
22
59
(3034860) Kappa light chains.free [Mass/volume] in Serum
296
772
4.19
101.94
1.8
3.5
mg/l
48.9
64.0
0.81
237
630
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
295
771
4.18
101.29
1.8
3.5
mg/l
37.1
76.0
1.37
239
630
(3039162) Centromere protein B Ab [Units/volume] in Serum
140
183
8.02
101.20
1.6
1.1
u/ml
70.0
60.4
—
13
7
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
293
767
4.17
100.36
1.9
2.7
g/l
0.2
1.2
6.93
262
660
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
332
952
3.84
100.14
2.2
1.9
ug/l
1.3
2.0
0.65
290
831
(40760892) CBC W Ordered Manual Differential panel - Blood
879
4392
2.49
98.33
11.3
4.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
176
307
6.07
97.20
1.6
1.1
u/ml
62.0
18.5
2.17
24
22
(3023520) Reticulocytes [#/volume] in Blood
526
2041
2.96
97.16
3.3
2.5
e9/l
71.0
70.2
0.14
378
1553
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
271
708
4.15
92.88
1.7
2.5
g/l
33.6
37.6
15.32
236
604
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
619
2702
2.68
90.83
2.1
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
247
620
4.29
89.21
1.7
2.6
g/l
0.0
0.0
0.00
227
576
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
281
781
3.90
88.27
3.0
2.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
613
2698
2.65
88.20
2.2
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
234
569
4.41
88.06
1.8
3.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
247
628
4.23
87.67
1.7
2.6
g/l
0.0
0.0
0.00
227
576
(3018677) aPTT in Platelet poor plasma by Coagulation assay
736
3550
2.48
87.28
3.1
2.1
s
28.9
29.9
4.48
715
3433
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
62
27
23.49
85.86
4.5
1.0
u/ml
112.3
—
—
12
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1702
11740
2.24
84.37
6.6
6.3
umol/l
10.2
11.8
6.93
1644
11107
(3007853) Bacteria identified in Skin by Aerobe culture
584
2567
2.63
83.82
2.4
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
171
341
5.29
81.63
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
765
3853
2.38
81.61
6.0
2.7
e6/l
1.1
1.2
0.12
539
2219
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
224
560
4.28
81.18
6.0
3.3
mg/l
1.7
1.6
0.60
210
506
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
175
358
5.16
81.15
1.8
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
129
198
6.80
80.66
1.4
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
983
5527
2.23
80.56
12.5
6.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
518
2192
2.69
79.91
8.4
3.5
mmol/l
1.7
2.0
1.52
455
1754
(3026493) Urate [Moles/volume] in Serum or Plasma
1007
5737
2.21
79.68
3.9
2.7
umol/l
2231.6
6266.1
3.70
907
4905
(3037756) Immunofixation for Serum or Plasma
210
507
4.41
79.61
1.4
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1385
8938
2.14
79.53
4.6
2.8
ug/l
182.0
133.8
6.60
1297
8161
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
177
374
5.00
79.03
1.6
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
121
178
7.07
78.69
2.4
2.0
e9/l
1.1
1.0
0.26
64
104
(3013826) Glucose [Moles/volume] in Serum or Plasma
1839
13306
2.23
77.84
7.6
4.7
mmol/l
6.7
6.8
0.48
1767
12482
(3012095) Magnesium [Moles/volume] in Serum or Plasma
734
3696
2.36
77.81
4.0
3.2
mmol/l
0.8
0.8
0.25
688
3430
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1020
5888
2.19
77.63
2.9
2.2
mg/l
3.2
3.1
0.71
893
4985
(3021447) Carbon dioxide [Partial pressure] in Venous blood
513
2198
2.65
76.96
8.5
3.5
kpa
5.8
5.8
0.08
503
2132
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
171
364
4.95
75.66
1.7
1.3
u/ml
15.8
16.8
—
6
8
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
260
761
3.68
75.44
2.2
2.3
ug/l
370.9
838.9
0.92
237
724
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
209
526
4.23
74.97
1.6
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
915
5117
2.20
74.88
6.9
3.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
158
318
5.22
74.57
1.4
1.2
u/ml
264.1
289.6
0.40
105
190
(3042936) Bacteria identified in Isolate by Culture
656
3199
2.39
74.38
2.5
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
460
1901
2.72
73.93
12.7
8.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1972
14827
2.27
73.65
7.8
4.8
e6/l
4391.4
1891.7
0.25
24
223
(3048929) Epstein Barr virus Ab [Presence] in Serum
201
500
4.27
73.19
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
150
295
5.33
72.65
1.6
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
155
318
5.11
71.55
1.8
1.4
u/ml
121.3
124.8
0.09
28
62
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
159
335
4.98
71.16
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
704
3611
2.29
70.51
6.3
2.9
e6/l
3.0
2.6
0.48
474
1992
(3010375) cycloSPORINE [Mass/volume] in Blood
78
80
10.01
67.99
23.4
25.4
ug/l
95.0
120.1
1.94
62
65
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
307
1074
3.10
66.72
9.3
3.7
mmol/l
24.1
24.1
0.00
282
967
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
105
161
6.75
65.64
1.9
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
202
548
3.91
65.24
1.8
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
86
108
8.20
64.12
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
86
108
8.20
64.12
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
86
108
8.20
64.12
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
20
23.39
63.58
5.2
4.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
138
284
5.07
63.41
1.6
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
60
46
13.32
63.18
6.2
4.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
86
110
8.05
63.15
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
86
110
8.05
63.15
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
86
110
8.05
63.15
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
68
64
10.88
62.92
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
344
1331
2.82
62.16
2.6
2.4
au/ml
32.9
25.3
—
8
61
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
146
321
4.75
62.03
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1395
9568
1.96
61.91
11.2
9.9
inr
1.2
1.3
1.03
393
2653
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
191
529
3.81
59.81
1.8
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
78
96
8.34
59.11
1.6
1.3
u/l
5.2
6.7
0.46
61
83
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
145
330
4.59
59.03
1.6
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
315
1195
2.86
58.93
1.4
1.3
au/ml
33.7
52.2
—
7
53
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
87
123
7.28
58.57
2.4
2.1
e6/l
444.4
552.5
0.62
74
105
(3037121) Protein [Mass/volume] in Urine
240
790
3.24
57.56
5.3
3.0
g/l
0.5
0.3
2.02
146
309
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
84
117
7.38
57.31
2.4
2.2
e9/l
0.2
0.2
0.86
76
104
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
164
426
4.04
56.16
5.3
3.3
%
61.6
58.4
2.18
164
426
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
178
504
3.71
53.91
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
385
1687
2.50
53.78
1.9
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1065
6901
1.90
53.74
6.6
3.2
mg/l
496.5
271.6
0.92
796
4314
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
107
206
5.37
52.97
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1093
7167
1.89
52.96
3.5
3.1
ng/l
1876.5
1577.2
0.85
981
6178
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
153
398
4.02
52.25
1.8
1.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
87
139
6.44
52.25
2.4
2.0
%
74.5
71.1
0.79
81
130
(3033658) Prothrombin time (PT) actual/Normal
910
5640
1.93
52.23
5.9
3.9
%
93.4
87.9
8.07
889
5501
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
44
27
16.55
52.20
12.5
14.9
mmol/l
4.9
5.6
0.70
44
27
(21494815) CD4 cells/100 lymphocytes in Specimen
89
147
6.23
51.73
2.3
1.9
%
48.1
45.1
0.23
15
17
(3009508) Creatinine [Moles/volume] in Urine
1085
7166
1.87
50.83
6.8
3.1
mmol/l
6.7
7.1
2.44
962
5950
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
793
4747
1.95
50.07
2.4
1.8
mg/l
1.6
1.3
1.29
653
3670
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
81
126
6.60
49.91
2.4
2.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
84
136
6.34
49.80
2.4
2.0
%
18.1
15.2
0.39
34
54
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
188
582
3.40
49.66
1.6
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1110
7427
1.85
49.54
4.0
3.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
130
313
4.32
49.22
1.8
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
231
816
3.00
48.92
4.1
3.0
u/ml
0.4
0.4
0.03
142
472
(3014148) Varicella zoster virus Ab [Titer] in Serum
96
180
5.50
48.91
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
145
382
3.96
48.64
3.2
3.8
%
1.1
1.5
0.76
127
294
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
92
167
5.67
48.53
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
288
1162
2.66
47.47
1.5
1.2
u/ml
188.7
211.5
0.17
271
1068
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
114
256
4.61
47.13
1.5
1.2
u/ml
4.6
5.7
0.28
46
113
(3024354) Oxygen [Partial pressure] in Venous blood
388
1806
2.34
47.03
6.7
2.9
kpa
5.1
4.5
3.44
376
1748
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
79
128
6.33
46.79
2.3
2.1
e6/l
611.6
658.7
0.22
47
58
(3020682) Albumin/Creatinine [Ratio] in Urine
1081
7270
1.82
46.68
8.1
4.0
mg/mmol
23.0
9.1
6.53
803
4508
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
37
20
18.75
46.56
2.5
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
92
176
5.38
45.85
2.4
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
483
2487
2.15
45.71
1.8
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
105
227
4.77
45.47
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
111
252
4.55
45.27
1.8
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1042
6980
1.81
45.21
3.1
2.5
u/l
60.5
57.6
0.54
977
6413
(3015377) Calcium [Moles/volume] in Serum or Plasma
1152
7960
1.79
44.93
3.8
3.4
mmol/l
2.3
2.4
4.66
1008
6865
(3029937) Albumin [Presence] in Urine by Test strip
899
5770
1.84
44.80
8.5
4.2
estimate
0.0
0.0
1.08
396
1861
(3008757) Leukocyte morphology finding [Identifier] in Blood
111
257
4.46
44.17
3.3
4.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
183
605
3.17
43.36
5.0
2.4
g/l
3.5
3.6
0.52
175
568
(3014111) Lactate [Moles/volume] in Serum or Plasma
410
2027
2.21
42.78
9.6
6.8
mmol/l
1.3
1.4
0.53
393
1958
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
97
209
4.78
42.17
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
743
4600
1.85
40.88
2.0
1.8
nmol/l
1161.9
1178.0
0.17
595
3424
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
152
467
3.39
40.55
1.3
1.2
mmol/l
3.8
3.9
0.21
139
440
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
55
72
7.78
39.56
2.8
2.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
161
523
3.21
39.24
1.3
1.3
mg/l
471.7
532.3
1.33
151
494
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1225
8856
1.71
38.91
5.4
3.9
ng/l
44.3
51.9
0.45
965
6451
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
167
558
3.13
38.82
1.4
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
49
57
8.74
38.79
1.2
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
525
2946
1.97
38.71
9.8
6.5
mmol/l
103.8
104.2
1.03
516
2874
(3037692) Legionella sp identified in Specimen by Organism specific culture
54
71
7.74
38.70
1.3
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
28
12
23.57
38.68
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
39
33
11.98
38.57
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
39
33
11.98
38.57
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
39
33
11.98
38.57
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
39
33
11.98
38.57
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
68
117
5.94
37.93
1.4
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
72
131
5.62
37.89
1.4
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1220
8853
1.70
37.88
2.4
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1140
8126
1.70
37.81
8.2
4.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
129
373
3.58
37.78
1.6
1.5
—
—
—
0
0
(3036489) Thrombin time
203
769
2.77
37.63
3.0
2.1
s
21.9
21.7
0.18
188
688
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
43
44
9.92
37.46
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
156
513
3.17
37.24
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
156
513
3.17
37.24
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
314
1472
2.28
36.99
2.0
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
175
618
2.96
36.92
3.3
2.3
%
99.2
88.8
7.28
169
584
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
48
58
8.41
36.87
2.4
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
304
1413
2.30
36.53
6.6
3.6
mmol/l
1.4
2.0
2.40
239
1043
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
99
244
4.18
36.33
1.5
1.5
%
52.6
62.8
1.38
62
151
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
105
271
3.99
36.21
1.5
1.2
u/ml
11.3
3.7
0.63
36
81
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
314
1488
2.26
36.01
6.7
3.7
kpa
5.1
5.2
0.86
297
1369
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1297
9650
1.67
35.97
2.3
2.0
pmol/l
92.9
94.2
0.46
726
4881
(3022313) Gas panel - Capillary blood
249
1072
2.46
35.54
6.8
3.8
—
—
—
0
0
(3009343) pH of Capillary blood
310
1471
2.25
35.41
6.8
3.7
ph
7.4
7.4
0.35
38
174
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
96
236
4.18
35.35
1.6
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
163
570
2.98
34.98
3.6
2.5
%
213.7
194.9
1.63
156
540
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
42
46
9.26
34.80
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
88
205
4.41
34.75
1.3
1.2
u/l
47.2
52.9
0.75
60
147
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
132
410
3.34
34.59
4.0
3.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
108
294
3.79
34.56
2.8
2.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
975
6785
1.69
34.52
3.7
3.2
u/l
38.1
35.3
0.20
933
6437
(4268621)
80
177
4.63
33.69
2.5
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
94
236
4.09
33.66
4.6
4.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
373
1940
2.07
33.64
8.2
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2406
21487
2.23
33.53
39.8
15.2
mg/l
23.3
25.1
2.36
2287
17197
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
143
5.07
33.41
1.8
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
369
1918
2.07
33.32
5.6
3.9
mmol/l
1.2
1.2
0.61
348
1666
(3027801) Oxygen [Partial pressure] in Arterial blood
474
2715
1.91
32.34
8.7
7.2
kpa
11.9
12.2
0.41
449
2583
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
474
2715
1.91
32.34
8.7
7.2
kpa
5.0
5.1
2.33
450
2583
(44790049)
95
248
3.94
32.25
1.6
1.4
—
—
—
0
0
(44790048)
95
248
3.94
32.25
1.6
1.4
—
—
—
0
0
(44806118)
95
248
3.94
32.25
1.6
1.4
—
—
—
0
0
(44790047)
95
248
3.94
32.25
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
825
5570
1.70
32.24
7.1
3.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
83
196
4.34
32.22
1.3
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
173
657
2.75
31.86
1.6
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
38
41
9.39
31.83
1.4
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
93
242
3.95
31.72
1.4
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
146
507
2.99
31.71
1.7
1.7
e6/l
9883.1
17346.5
1.68
112
366
(3042631) Mycobacterium sp identified in Specimen
110
322
3.52
31.62
3.2
2.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
88
221
4.08
31.50
1.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
130
427
3.15
31.08
1.3
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
44
59
7.57
31.00
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
822
5623
1.67
30.16
1.8
1.6
nmol/l
18.7
20.8
4.12
735
4748
(3019832) Treponema pallidum Ab [Presence] in Serum
246
1133
2.29
30.02
1.6
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
212
918
2.42
29.77
7.2
4.0
mmol/l
24.6
24.9
0.70
200
845
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
112
345
3.34
29.74
1.3
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
425
2414
1.90
29.54
9.3
7.6
%
95.7
95.6
0.13
407
2322
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
136
473
2.98
29.45
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
136
476
2.96
29.12
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
463
2718
1.85
28.99
8.9
7.2
mmol/l
1.0
1.1
0.47
377
2121
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
61
122
5.09
28.95
1.9
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61
122
5.09
28.95
1.9
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49
80
6.22
28.82
1.6
2.6
u/ml
80656.4
30371.3
0.26
12
16
(3004119) Hemoglobin [Mass/volume] in Venous blood
289
1458
2.10
28.04
6.8
3.0
g/l
120.6
127.9
6.00
284
1419
(21494814) CD8 cells/100 lymphocytes in Specimen
47
76
6.28
27.91
2.4
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
172
696
2.57
27.89
4.3
3.7
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
42
61
6.98
27.58
4.0
2.1
%
8.6
11.2
0.35
34
53
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
75
185
4.14
27.52
1.9
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
53
98
5.50
27.44
1.5
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
34
39
8.82
27.18
3.1
1.9
e6/l
116.1
157.9
0.30
18
14
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
331
1777
1.98
27.04
3.6
2.7
ml/min/173m2
54.3
62.3
3.06
162
746
(3017354) Segmented neutrophils/100 leukocytes in Blood
86
240
3.67
26.57
2.8
3.7
%
63.2
57.2
1.32
64
154
(3048689) Calprotectin [Mass/mass] in Stool
400
2300
1.87
26.57
2.3
2.2
ug/g
208.6
143.2
1.39
335
1796
(3007566) Smooth muscle Ab [Titer] in Serum
138
515
2.77
26.26
1.4
1.2
titre
60.9
85.0
0.77
11
36
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
58
123
4.80
25.74
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
107
352
3.13
25.53
1.6
1.5
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
63
144
4.46
25.52
1.3
1.2
mmol/l
2.1
2.1
0.16
55
136
(3045414) Leukocytes [Presence] in Urine
212
983
2.26
25.38
2.4
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
678
4587
1.64
25.18
5.4
3.8
ng/l
203.7
374.7
2.10
562
3764
(3024471) HLA-A [Type]
37
52
7.20
25.02
1.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
119
4.79
24.80
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
126
462
2.81
24.79
1.3
1.4
e6/l
17.7
29.3
0.34
97
356
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
126
462
2.81
24.79
1.4
1.4
e6/l
1201.8
901.9
0.12
104
376
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
413
2449
1.81
24.72
4.3
3.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
77
210
3.75
24.61
1.2
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
224
1082
2.17
24.23
6.0
2.4
%
0.7
0.7
0.01
215
1037
(3034770) Mitochondria Ab [Titer] in Serum
135
520
2.68
24.17
1.4
1.2
titre
680.0
1113.1
—
5
13
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
59
134
4.48
24.10
1.2
1.1
mg/l
38.5
40.9
0.17
49
116
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
269
1396
2.03
24.07
1.7
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
381
2224
1.83
23.97
10.1
8.0
g/l
115.7
120.7
4.96
368
2142
(3013293) Extractable nuclear Ab [Presence] in Serum
20
12
16.79
23.74
2.5
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
43
75
5.81
23.68
1.3
1.1
u/ml
66.9
8.7
—
7
9
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
39
62
6.37
23.55
2.2
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
35
50
7.08
23.33
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
400
2391
1.79
23.21
9.2
4.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
969
7235
1.53
23.16
3.4
2.5
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
20
13
15.49
22.80
1.0
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
56
128
4.45
22.70
1.1
1.1
mg/l
261.0
280.9
0.31
49
114
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
125
4.47
22.46
1.1
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
355
2068
1.83
22.40
2.4
2.4
u/l
35.1
63.0
0.63
307
1748
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1311
10479
1.49
22.33
4.9
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
201
962
2.18
22.23
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
241
1238
2.04
22.13
11.1
9.3
mmol/l
24.5
24.4
0.15
223
1156
(3016650) Hepatitis A virus Ab [Presence] in Serum
90
292
3.15
22.00
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
47
96
4.97
21.81
3.5
7.2
mg/l
96.2
68.0
0.48
40
70
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
651
4510
1.59
21.40
2.8
3.1
mmol/l
2.5
2.5
1.62
571
3970
(3027273) Bicarbonate [Moles/volume] in Venous blood
231
1193
2.03
20.88
6.7
3.2
mmol/l
25.1
25.3
0.57
224
1154
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
82
261
3.21
20.71
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
44
90
4.95
20.40
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
120
476
2.59
20.28
6.5
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
765
5555
1.53
20.20
3.2
2.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
48
108
4.51
19.87
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
108
4.51
19.87
1.1
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
88
300
3.00
19.79
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
89
306
2.97
19.72
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
49
113
4.40
19.67
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
187
913
2.13
19.64
2.3
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1976
17383
1.53
19.63
41.5
18.7
%
14.3
13.8
34.12
1955
16968
(4306422)
80
260
3.14
19.53
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
132
558
2.44
19.51
1.0
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
24
6
40.39
19.50
2.2
1.0
titre
438.6
—
—
7
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
17
11
15.55
19.36
1.2
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
155
712
2.25
18.95
1.4
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
22
23
9.64
18.78
1.6
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
48
113
4.31
18.78
1.2
1.1
u/l
1.1
1.2
0.90
29
63
(3016018) Differential panel - Cerebral spinal fluid
71
220
3.29
18.75
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
77
251
3.13
18.71
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
392
2467
1.69
18.69
2.6
2.7
umol/l
7.2
9.1
1.33
341
2162
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
26
35
7.49
18.24
1.3
2.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
22
24
9.23
18.21
1.1
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
123
520
2.43
18.19
5.3
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
195
998
2.03
18.05
2.5
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
182
909
2.08
18.00
2.7
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
188
3.41
17.67
1.3
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
65
199
3.32
17.52
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
65
199
3.32
17.52
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
65
199
3.32
17.52
1.6
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
458
3047
1.61
17.46
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
111
457
2.49
17.39
1.8
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
48
120
4.06
17.38
1.4
1.2
u/l
22.6
18.5
0.36
42
103
(3027315) Oxygen [Partial pressure] in Blood
124
538
2.37
17.32
5.8
4.9
kpa
8.5
8.4
0.11
124
530
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
85
307
2.83
17.26
7.9
6.8
mg/l
12.5
12.0
0.46
80
283
(3017732) Neutrophils [#/volume] in Blood
250
1414
1.85
17.19
3.3
3.1
e9/l
5.0
4.0
4.69
186
1073
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
61
184
3.37
16.84
1.5
1.4
%
31.4
30.6
0.05
35
112
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
345
2157
1.69
16.76
2.8
2.4
ug/l
4.9
6.6
2.29
288
1878
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
61
185
3.35
16.70
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
348
2185
1.68
16.63
2.4
2.2
g/l
0.2
0.2
3.96
325
2037
(3028433) Virus identified in Specimen by Culture
36
74
4.92
16.62
1.1
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
41
95
4.37
16.39
1.2
1.1
ratio
1.1
1.1
0.21
15
33
(3019060) Gas panel - Arterial blood
272
1605
1.77
16.24
4.9
4.8
—
—
—
0
0
(3025315) Body weight
17
15
11.40
16.21
6.2
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
132
607
2.24
16.11
2.0
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
122
543
2.31
16.09
1.3
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
121
537
2.31
16.07
5.8
4.9
mmol/l
2.4
2.8
0.74
91
371
(3013290) Carbon dioxide [Partial pressure] in Blood
121
538
2.31
16.00
5.8
4.9
kpa
4.9
5.1
1.50
121
531
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
36
78
4.66
15.64
1.1
1.1
ng/l
247.3
573.6
0.39
13
19
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
33
67
4.97
15.46
1.1
1.1
miu/ml
1516.4
1637.8
0.24
33
67
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
44
113
3.94
15.39
1.3
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1400
11817
1.39
15.19
3.1
2.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
73
263
2.83
14.93
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2401
22454
1.70
14.78
36.2
18.1
mmol/l
139.4
139.6
5.26
2373
21861
(3022217) INR in Platelet poor plasma by Coagulation assay
464
3219
1.53
14.51
34.3
27.5
inr
1.3
1.4
0.54
43
433
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2191
20079
1.51
14.51
7.7
6.1
mmol/mol
40.7
40.3
0.77
2084
18347
(3029075) Extractable nuclear Ab panel - Serum
28
52
5.43
14.48
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
45
123
3.70
14.44
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
45
123
3.70
14.44
1.9
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2402
22505
1.68
14.18
37.0
18.3
mmol/l
4.0
4.0
0.34
2369
21868
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
16
16
10.05
14.03
1.1
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
48
140
3.47
14.00
4.0
3.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
204
1156
1.83
13.91
1.4
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
26
47
5.58
13.83
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
38
95
4.04
13.80
1.2
1.3
%
6.2
3.8
—
9
18
(4027681)
39
100
3.94
13.69
1.3
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
332
2160
1.61
13.68
3.4
3.0
ng/l
233.9
215.7
0.28
305
1975
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
28
55
5.13
13.63
1.1
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
40
105
3.85
13.60
1.1
1.1
u/l
23.2
24.7
0.08
35
72
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
426
2940
1.53
13.58
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1543
13364
1.37
13.57
3.9
3.2
u/l
57.6
51.4
1.15
1464
12282
(3008536) Aspergillus sp Ab [Presence] in Serum
24
41
5.90
13.52
1.8
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
16
17
9.46
13.44
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
130
641
2.08
13.34
6.1
4.6
ph
7.4
7.4
0.75
121
530
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
42
116
3.66
13.29
3.1
3.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
49
152
3.27
13.00
1.4
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1847
16520
1.38
12.94
4.6
4.1
pmol/l
15.2
14.9
4.45
1710
14818
(3011436) Histone Ab [Units/volume] in Serum
22
36
6.15
12.93
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
287
1830
1.64
12.81
9.3
4.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
57
196
2.95
12.73
1.5
1.3
e6/l
12262.2
106992.6
1.18
37
138
(3023410) Appearance of Cerebral spinal fluid
61
219
2.83
12.61
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
107
501
2.18
12.55
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
82
343
2.43
12.49
1.8
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
630
4767
1.42
12.47
8.3
4.3
kg/l
1.0
1.0
0.52
71
721
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
23
41
5.65
12.42
1.7
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
34
85
4.04
12.37
1.1
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
14
14
10.05
12.24
1.1
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
27
57
4.78
12.12
1.4
1.5
ug/l
0.2
0.4
1.76
15
31
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
210
1251
1.74
12.09
12.2
10.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
27
58
4.69
11.88
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2186
20224
1.45
11.88
29.8
14.5
ml/min/173m2
71.6
76.9
19.06
1998
16674
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
49
161
3.08
11.86
1.6
1.5
u/l
12.8
13.3
0.19
44
153
(40761511) CBC panel - Blood by Automated count
2357
22145
1.56
11.81
29.4
14.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
579
4355
1.42
11.77
1.3
1.2
u/ml
1.2
1.4
0.14
140
1092
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
12
10
12.05
11.74
2.8
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
72
292
2.51
11.74
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
125
639
2.00
11.65
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
72
294
2.49
11.57
1.5
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
21
37
5.71
11.47
1.3
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
37
104
3.59
11.45
4.5
4.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
25
52
4.84
11.43
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
125
645
1.98
11.36
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
104
502
2.12
11.32
3.1
2.5
%
15.9
16.0
0.02
53
243
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
123
632
1.99
11.31
1.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
72
298
2.46
11.26
1.6
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
40
120
3.37
11.23
2.6
2.8
%
37.9
39.7
0.13
15
44
(3025468) Yersinia sp identified in Specimen by Organism specific culture
71
293
2.46
11.17
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2407
22777
1.58
11.06
38.8
18.0
umol/l
97.8
78.8
29.14
2407
22768
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
71
295
2.45
11.01
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
71
295
2.45
11.01
1.5
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
23
46
5.03
10.99
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
118
604
2.00
10.98
4.9
3.2
mmol/l
24.0
25.1
2.03
106
518
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
42
133
3.19
10.83
1.6
1.5
u/l
4.2
6.8
0.51
21
63
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
17
26
6.57
10.63
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
125
661
1.93
10.60
1.5
1.5
ug/g
289.2
277.5
0.25
65
380
(4035726)
298
2007
1.55
10.50
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
344
2390
1.50
10.49
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
89
421
2.15
10.23
1.5
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
241
1556
1.60
10.19
1.2
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
24
6.70
10.18
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
54
4.48
10.01
1.3
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
124
3.18
10.01
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
124
3.18
10.01
1.4
1.2
—
—
—
0
0
(3036603) Volume of Urine
43
145
3.00
10.00
1.5
1.4
ml
2242.2
1637.0
0.51
11
32
(4010399)
241
1565
1.59
9.95
1.6
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2401
22795
1.54
9.87
24.6
10.7
u/l
24.2
25.3
2.37
2372
21867
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
36
110
3.30
9.85
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
25
59
4.27
9.84
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
47
169
2.81
9.76
1.1
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
25
61
4.13
9.43
1.4
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
61
255
2.42
9.39
4.1
3.7
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
94
474
2.02
9.17
1.6
2.8
umol/l
26.7
35.9
5.63
80
389
(3008152) Bicarbonate [Moles/volume] in Arterial blood
230
1506
1.58
9.17
8.9
6.9
mmol/l
24.2
24.6
0.73
219
1402
(3028679) Herpes simplex virus Ab [Presence] in Serum
28
76
3.71
9.16
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
161
966
1.71
9.07
6.8
4.3
—
—
—
0
0
(3013512) EKG study
833
6869
1.31
9.00
5.3
4.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
24
59
4.10
8.98
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
24
59
4.10
8.98
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
17
31
5.51
8.97
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
68
3.85
8.95
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
39
4.90
8.83
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1710
15485
1.29
8.80
4.7
4.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
35
113
3.13
8.79
1.3
1.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
17
32
5.34
8.68
1.9
1.4
ng/l
140.4
110.0
0.38
17
32
(3026389) Candida sp identified in Specimen by Organism specific culture
65
293
2.25
8.47
1.4
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
36
123
2.95
8.23
1.9
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
36
123
2.95
8.23
1.9
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
36
123
2.95
8.23
1.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
36
123
2.95
8.23
1.9
1.7
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
23
59
3.92
8.15
2.0
2.6
%
216.7
183.1
0.62
23
52
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
40
146
2.77
8.13
1.5
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
40
147
2.75
8.03
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
268
1867
1.48
8.02
1.8
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
34
116
2.96
7.81
2.1
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
155
959
1.65
7.81
1.4
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2111
19773
1.32
7.80
5.6
4.9
mu/l
1.9
2.0
1.77
1966
17834
(3028271) Lactate [Moles/volume] in Capillary blood
78
391
2.02
7.78
2.3
1.9
mmol/l
1.7
1.7
0.01
78
381
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
57
3.88
7.70
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
39
145
2.71
7.67
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
191
1253
1.56
7.57
2.5
2.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
43
171
2.54
7.42
1.1
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
59
271
2.20
7.39
1.5
1.3
mu/l
180.8
44.8
0.77
54
243
(3011648) Oxygen content in Venous blood
44
179
2.48
7.25
5.8
1.7
%
10.7
11.0
0.21
44
179
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
55
3.84
7.25
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
19
6.34
7.24
1.1
1.1
—
—
—
0
0
(44806071)
12
19
6.34
7.24
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
83
437
1.93
7.23
3.6
2.8
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
7
15.78
7.22
4.5
4.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
622
5056
1.30
7.21
1.8
1.7
pmol/l
33208014.5
28306416.4
0.09
530
4144
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
30
5.02
7.18
1.1
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
11
16
6.90
7.15
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
31
107
2.92
7.01
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
31
107
2.92
7.01
1.4
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
66
3.51
6.99
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
92
508
1.84
6.94
2.8
2.2
g/l
126.8
128.0
0.22
64
377
(3027456) Digoxin [Moles/volume] in Serum or Plasma
105
604
1.77
6.93
3.4
3.3
nmol/l
0.9
0.8
0.36
80
468
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
53
241
2.22
6.83
4.8
2.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
56
266
2.13
6.50
1.2
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
11
18
6.13
6.43
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
28
96
2.94
6.42
1.9
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
28
96
2.94
6.42
1.9
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
22
65
3.40
6.41
1.1
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
10
7
14.33
6.39
1.7
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
28
97
2.91
6.31
2.0
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
40
4.02
5.89
1.4
1.1
—
—
—
0
0
(4015189)
22
69
3.21
5.87
2.1
2.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
9
11.15
5.79
3.2
4.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
35
143
2.47
5.78
1.5
1.2
u/ml
0.9
1.1
0.10
21
72
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
87
503
1.75
5.70
1.5
1.9
iu/l
5.3
4.5
0.16
25
164
(3001686) Cold agglutinin [Titer] in Serum or Plasma
17
46
3.71
5.64
1.2
1.4
—
141.3
—
0
8
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
180
1247
1.48
5.58
3.0
3.3
pmol/l
4.2
4.4
1.57
152
1099
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
9
7
12.89
5.58
6.0
5.0
umol/l
482.4
393.6
—
9
7
(3017569) Oxygen content in Arterial blood
29
111
2.63
5.47
2.0
2.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
687
5819
1.24
5.47
1.8
1.6
mmol/l
1.4
1.4
0.42
595
4848
(3043409) Potassium [Moles/volume] in Arterial blood
116
733
1.61
5.46
5.7
3.8
mmol/l
4.0
3.9
1.07
110
679
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
39
174
2.26
5.33
1.4
1.3
u/l
12.2
11.5
0.13
33
160
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
63
3.19
5.31
1.5
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
37
162
2.30
5.28
1.2
1.2
mmol/l
32.5
35.1
0.33
32
141
(3028468) Fragments [Presence] in Blood by Light microscopy
5
0
+∞
5.21
4.0
0.0
—
—
—
0
0
(3000012) Reticulocyte production index
29
116
2.52
5.04
2.0
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
27
4.46
5.03
1.3
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
27
4.46
5.03
1.3
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
27
4.46
5.03
1.3
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
61
3.13
4.91
1.1
1.4
%
114.2
86.1
—
6
33
(3023199) Leukocytes [#/volume] in Pleural fluid
58
311
1.88
4.90
1.6
1.5
e6/l
1355.6
1574.5
0.28
45
223
(40761539) Cells [Type] in Urine sediment by Light microscopy
18
56
3.23
4.89
1.2
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
27
106
2.56
4.88
3.9
2.5
mmol/l
8.5
9.7
1.00
22
85
(3007930) Methemoglobin/Hemoglobin.total in Blood
144
982
1.49
4.86
5.8
5.4
%
0.9
0.9
0.06
135
919
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
50
256
1.97
4.83
1.2
1.3
pmol/l
498.3
285.8
1.15
38
196
(21494434) Karyotype in Bone marrow
45
223
2.04
4.76
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
53
280
1.91
4.69
1.6
1.5
e6/l
30089.0
89396.4
0.92
32
165
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
43
3.50
4.61
1.1
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
8
8
10.03
4.52
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
50
263
1.92
4.50
1.7
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
76
456
1.69
4.44
1.3
1.2
miu/ml
213.5
218.4
0.04
20
195
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
30
4.01
4.43
1.7
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
52
279
1.88
4.42
1.7
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
90
1394
0.63
4.41
1.5
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
47
244
1.94
4.40
1.7
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
35
3.73
4.36
1.2
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
17
55
3.10
4.36
1.2
1.2
nmol/l
181.3
126.8
—
10
41
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
26
4.24
4.35
1.1
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
29
125
2.33
4.34
4.2
2.8
ph
7.4
7.4
0.14
13
40
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
50
3.21
4.33
10.6
8.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2433
23635
1.34
4.29
51.1
22.7
g/l
128.6
133.7
54.98
2413
23232
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
142
992
1.46
4.28
5.9
5.4
%
1.5
1.6
0.27
133
926
(3007461) Platelets [#/volume] in Blood
2431
23619
1.33
4.23
50.8
22.6
e9/l
263.5
248.1
21.30
2402
22950
(3003434) Protein [Mass/volume] in Pleural fluid
60
343
1.77
4.18
1.7
1.5
g/l
29.1
31.8
0.93
52
310
(3024731) MCV [Entitic volume]
2431
23625
1.33
4.17
50.7
22.5
fl
92.0
91.3
9.77
2412
23218
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
62
2.92
4.17
1.1
1.1
%
92.3
85.8
—
6
33
(3035941) MCH [Entitic mass]
2431
23627
1.33
4.15
50.6
22.5
pg
30.2
30.3
2.33
2412
23218
(3026361) Erythrocytes [#/volume] in Blood
2431
23628
1.33
4.14
50.8
22.6
e12/l
4.3
4.4
36.51
2395
22871
(3009871) Measles virus Ab [Titer] in Serum
17
57
3.00
4.12
1.6
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
82
513
1.62
4.11
1.1
1.1
u/ml
0.9
5.9
—
6
46
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2104
20123
1.22
4.07
4.8
4.1
mmol/l
1.3
1.3
2.80
1946
18076
(3010813) Leukocytes [#/volume] in Blood
2431
23636
1.32
4.07
50.9
22.6
e9/l
7.7
6.8
54.54
2396
22881
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
47
3.20
4.05
1.7
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2001
19051
1.20
4.04
36.1
16.6
%
37.6
39.0
8.08
1301
12713
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
54
922
0.58
3.97
1.3
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
84
534
1.59
3.95
3.3
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
46
248
1.87
3.89
1.4
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
24
4.18
3.88
1.6
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
73
451
1.64
3.86
1.7
1.4
mmol/l
50.5
60.8
2.50
62
364
(40757373) Influenza virus identified in Isolate
16
54
2.97
3.84
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
86
1302
0.65
3.83
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
647
5628
1.20
3.78
1.5
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
48
266
1.82
3.74
1.1
1.1
g/l
1.6
1.5
0.30
43
238
(3018851) Theophylline [Moles/volume] in Serum or Plasma
11
30
3.68
3.64
1.5
1.6
umol/l
60.7
40.3
0.54
11
30
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
17
62
2.75
3.58
1.3
1.4
%
38.2
22.7
0.78
12
50
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
47
263
1.80
3.56
1.3
1.3
nmol/l
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
92
2.40
3.56
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
271
1.79
3.54
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
46
792
0.57
3.53
1.9
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
589
6744
0.84
3.53
3.3
3.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
8
13
6.17
3.50
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
107
740
1.46
3.46
1.7
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
165
1233
1.36
3.44
6.8
3.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
20
82
2.45
3.38
3.6
2.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
10
27
3.71
3.35
1.7
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
37
3.25
3.34
1.3
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
8
14
5.73
3.34
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
8
14
5.73
3.34
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
43
3.03
3.25
9.3
8.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2180
21041
1.20
3.21
5.4
4.6
mmol/l
4.6
4.6
0.33
2034
19201
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
84
568
1.49
3.07
2.9
2.3
ug/min
283.6
108.4
1.15
53
335
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
56
2.69
3.05
1.5
1.3
%
44.0
27.6
—
6
38
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
8
7.51
3.05
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2160
20858
1.19
3.03
5.4
4.5
mmol/l
1.5
1.5
6.14
2007
18907
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
5
10.02
2.98
1.4
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
12
40
3.01
2.97
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
357
1.61
2.93
2.1
2.1
u/l
7437.6
2527.1
0.37
20
143
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
17
4.72
2.92
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
192
1508
1.29
2.88
4.6
3.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
102
2.17
2.86
1.5
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
50
305
1.65
2.86
2.8
2.3
mg/l
25.8
23.9
0.11
19
75
(3048879) Bone marrow aspiration report
18
77
2.35
2.81
1.9
1.6
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
13
47
2.77
2.81
1.3
1.2
mmol/l
1.2
1.5
—
5
32
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
47
2.77
2.81
1.1
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
23
3.92
2.77
1.3
1.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
7
14
5.01
2.73
2.1
4.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.01
2.73
1.1
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
14
5.01
2.73
1.6
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
19
4.22
2.67
2.3
3.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
19
4.22
2.67
4.5
7.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
341
2888
1.21
2.64
5.1
4.7
%
33.1
33.1
0.05
275
1872
(3004775) Volume in Urine collected for unspecified duration
34
192
1.78
2.58
2.6
2.2
ml
905.8
622.1
2.68
28
123
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
36
207
1.75
2.58
1.5
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
50
2.61
2.53
1.7
1.4
ug/l
8.2
9.1
0.56
13
50
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
23
115
2.01
2.50
1.3
1.8
u/field
4.9
2.2
0.87
18
83
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.38
2.47
1.3
2.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
21
3.82
2.46
1.1
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
21
3.82
2.46
1.1
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
45
2.67
2.45
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
76
2.24
2.44
1.2
2.9
umol/l
58.0
122.7
1.38
11
43
(3032057) Clostridioides difficile [Presence] in Stool
14
58
2.42
2.37
2.4
1.9
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
17
4.13
2.36
1.4
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
71
2.26
2.34
5.6
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
16
71
2.26
2.34
5.6
2.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
58
388
1.51
2.31
1.4
1.4
u/l
15.6
10.3
1.10
43
313
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
105
2.01
2.30
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
45
285
1.59
2.28
1.2
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2213
21534
1.16
2.26
5.9
5.1
mmol/l
2.6
2.7
4.81
2068
19549
(3047181) Lactate [Moles/volume] in Blood
101
752
1.36
2.26
6.5
6.5
mmol/l
1.2
1.3
0.26
88
659
(3039443) Prostate specific Ag panel - Serum or Plasma
15
312
0.48
2.23
1.5
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
29
3.11
2.22
1.1
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
24
128
1.88
2.21
1.8
2.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
16
73
2.20
2.21
1.1
1.2
g/l
28.8
39.0
—
5
37
(3006462) Nitrate [Presence] in Urine
20
100
2.01
2.20
6.1
4.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
39
241
1.63
2.19
1.7
1.4
mmol/l
6.8
6.6
0.14
33
227
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
152
1.78
2.12
1.7
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
159
1276
1.26
2.08
1.2
1.2
iu/ml
173.7
133.5
0.50
51
468
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
31
2.91
2.07
2.0
2.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
10
5.01
2.07
1.2
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
23
124
1.86
2.07
1.7
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2158
20996
1.15
2.06
5.8
4.8
mmol/l
5.9
6.0
2.12
2003
18859
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
(4094501)
78
568
1.38
2.03
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
167
1354
1.25
2.01
1.3
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
32
2.82
2.00
2.0
2.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
65
460
1.42
1.99
1.8
1.6
mu/l
368.3
299.9
0.50
60
423
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
296
2547
1.18
1.96
2.6
4.1
ug/l
7.3
20.1
1.92
235
2083
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
11
4.55
1.94
1.8
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
38
242
1.58
1.93
1.1
1.1
u/ml
8.6
2.2
—
10
94
(3002256) Pathology report gross observation
333
2899
1.17
1.92
1.4
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
78
2.06
1.90
1.3
1.6
umol/l
30.4
29.0
0.23
16
73
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
78
2.06
1.90
1.1
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
46
308
1.50
1.88
4.8
2.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
22
3.19
1.88
1.3
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
46
2.40
1.85
1.1
2.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
7
23
3.05
1.80
1.6
1.5
—
—
—
0
0
(4211845)
20
109
1.84
1.77
6.1
4.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
46
664
0.69
1.77
2.9
1.6
mg/l
13.0
3.8
0.95
29
486
(3035320) C reactive protein [Mass/volume] in Body fluid
26
154
1.70
1.76
3.6
2.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
67
2.10
1.76
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
72
532
1.36
1.75
7.5
7.5
mmol/l
11.9
11.2
1.17
65
474
(3018572) Chloride [Moles/volume] in Blood
72
532
1.36
1.75
7.5
7.6
mmol/l
104.9
105.1
0.15
65
474
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
13
3.85
1.71
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
77
578
1.34
1.70
1.4
1.4
iu/l
30.6
30.6
0.00
65
492
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
49
0.00
1.68
0.0
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
24
141
1.71
1.68
1.6
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
25
149
1.68
1.66
4.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
91
1.87
1.60
1.1
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
30
190
1.59
1.60
1.6
1.4
u/ml
17.5
20.2
—
6
40
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
32
2.50
1.59
7.1
8.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
20
3.00
1.58
1.2
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
35
231
1.52
1.57
1.5
1.9
—
—
—
0
0
(4198724)
11
50
2.20
1.57
2.1
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
84
652
1.30
1.51
5.6
4.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
21
123
1.71
1.50
2.2
1.3
nmol/l
1.2
1.1
0.06
15
96
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
124
1.70
1.47
2.7
2.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
45
2.23
1.46
2.2
2.9
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
38
2.37
1.45
1.4
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
22
2.73
1.43
1.3
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
76
588
1.30
1.41
1.3
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
29
2.42
1.39
1.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
23
2.61
1.36
1.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
14
75
1.87
1.34
1.7
1.9
—
—
—
0
0
(4281824)
14
245
0.57
1.30
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
716
6702
1.09
1.26
4.7
5.2
ug/l
3.7
3.3
0.12
624
5954
(40768795) Lymph node Pathology biopsy report
31
215
1.45
1.16
1.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
35
249
1.41
1.14
1.6
1.3
mosm/kgh2o
279.2
277.7
0.12
30
181
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
151
1.53
1.11
1.3
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
41
1.95
1.08
1.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
32
2.19
1.08
1.1
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
324
2943
1.11
1.06
13.2
7.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
29
203
1.43
1.05
5.1
2.9
mg/l
87.5
29.7
0.85
20
149
(3034274) Bile acid [Moles/volume] in Serum --fasting
24
162
1.49
1.04
2.5
2.1
umol/l
8.3
11.6
0.35
19
108
(3020717) Zinc [Moles/volume] in Serum or Plasma
14
83
1.69
1.01
1.6
1.4
umol/l
11.0
23.8
3.61
14
78
(3022689) Creatine [Moles/volume] in Urine
10
53
1.89
1.01
2.9
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
35
2.00
1.00
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
61
1.81
0.98
1.8
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
269
0.67
0.93
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
47
599
0.78
0.92
1.7
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
195
0.61
0.90
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
155
1361
1.15
0.90
1.6
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
21
144
1.46
0.87
1.4
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
70
579
1.21
0.83
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
33
433
0.76
0.82
1.1
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
55
446
1.24
0.79
2.4
1.6
nmol/l
1.0
0.8
1.12
40
366
(4024509)
31
235
1.32
0.75
1.5
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
26
1.92
0.70
2.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
258
1.28
0.67
1.1
1.1
—
—
—
0
0
(4133840)
7
43
1.63
0.66
1.0
1.2
—
—
—
0
0
(4212803)
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
26
197
1.32
0.65
1.9
1.4
u/l
33.2
27.3
0.35
21
156
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
50
1.60
0.61
11.0
1.8
mmol/l
1.1
1.2
—
8
50
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
14
97
1.45
0.59
1.1
1.3
mmol/l
5.8
6.2
0.69
14
92
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
39
320
1.22
0.55
1.7
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
150
1.34
0.55
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
98
876
1.12
0.51
2.9
3.3
u/ml
55.9
4829.3
0.87
78
741
(3025130) Human papilloma virus identified in Specimen
25
198
1.27
0.49
2.0
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
135
1233
1.10
0.48
1.6
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
47
1.49
0.47
1.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
299
0.80
0.46
4.9
2.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
2.6
2.1
—
—
—
0
0
(44806420)
5
83
0.60
0.45
2.0
2.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
164
0.73
0.45
1.0
1.1
u/ml
8.4
4.1
—
5
64
(37021550) Renin [Units/volume] in Plasma --upright
7
51
1.37
0.44
1.0
1.2
mu/l
57.3
42.4
—
7
38
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
184
1.25
0.43
3.6
5.0
u/ml
24.1
59.7
—
5
50
(44813793)
16
122
1.31
0.42
1.1
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
20
158
1.27
0.41
1.0
1.0
ng/l
661.4
681.4
0.10
13
96
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
20
158
1.27
0.41
1.0
1.0
ng/l
41.4
45.1
0.17
14
97
(1617658) Protocol used for examination of sentinel lymph nodes
15
195
0.77
0.41
1.1
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
3.9
—
0
16
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
74
664
1.12
0.39
1.5
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
35
1.43
0.39
1.8
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
18
142
1.27
0.38
3.3
2.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
80
1.38
0.38
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
189
1.22
0.36
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
338
1.16
0.35
1.2
1.1
iu/ml
33.2
1753.0
—
6
75
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
555
5379
1.04
0.35
4.1
4.5
%
21.5
21.8
0.16
278
2712
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
126
0.71
0.35
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
167
0.78
0.34
1.3
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
35
303
1.16
0.33
3.5
4.9
umol/l
302.4
363.4
1.24
26
261
(4146454)
31
266
1.17
0.32
3.0
2.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
248
1.17
0.31
1.2
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
19
156
1.22
0.31
1.0
1.0
ng/l
326.1
318.3
0.05
13
97
(3020650) Glucose [Presence] in Urine
7
53
1.32
0.30
2.0
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
249
1.17
0.30
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
55
1.27
0.30
1.0
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
24
203
1.18
0.30
1.7
2.2
u/field
0.6
2.4
—
10
68
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
221
2109
1.05
0.29
1.5
1.8
%
1.7
1.5
1.82
189
1805
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
238
0.84
0.28
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
29
251
1.16
0.28
1.7
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
94
1.28
0.28
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
237
0.84
0.27
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
247
0.85
0.27
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
236
0.85
0.26
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
236
0.85
0.26
1.4
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
338
1.13
0.26
1.2
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
72
0.69
0.26
1.8
2.1
—
—
—
0
0
(4034850)
67
727
0.92
0.25
25.3
11.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
45
406
1.11
0.25
2.2
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
138
1309
1.06
0.24
2.0
2.2
nmol/l
13.2
12.5
0.44
114
1144
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
15
126
1.19
0.21
1.4
1.5
g/l
0.7
1.0
3.24
15
126
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
192
1.15
0.20
3.2
2.7
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
102.1
—
0
14
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
1.0
1.1
—
6.0
—
0
8
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
59
1.19
0.18
1.3
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
339
1.09
0.17
2.4
2.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
80
1.13
0.15
1.9
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
19
172
1.11
0.11
2.2
2.8
mmol/l
6.9
7.0
0.18
19
109
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
178
0.90
0.11
1.0
1.0
u/ml
1.4
3.2
—
9
66
(3006653) Thiamine [Moles/volume] in Blood
12
105
1.14
0.11
1.2
1.3
nmol/l
179.2
140.1
0.86
12
105
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
105
1.14
0.11
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
198
0.91
0.10
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
413
0.94
0.10
1.5
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
49
514
0.95
0.10
8.2
3.8
mg/l
34.3
27.1
0.74
29
330
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
135
0.89
0.09
1.3
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
1.6
2.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
145
1.10
0.09
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
277
0.94
0.08
1.0
1.1
u/ml
0.6
1.4
—
7
112
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
70
0.86
0.07
1.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
388
3837
1.01
0.07
3.0
3.2
ug/l
0.7
0.8
1.60
296
2624
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
221
2176
1.02
0.07
1.6
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
194
0.93
0.07
1.4
1.4
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
7
81
0.86
0.07
1.0
1.0
—
4.7
—
0
9
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
101
986
1.03
0.07
1.1
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
128
1.09
0.06
5.1
6.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1755
17599
0.99
0.06
46.2
20.1
g/l
328.4
331.7
42.17
1743
17447
(3013139) Helicobacter pylori Ag [Presence] in Stool
144
1414
1.02
0.06
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
45
433
1.04
0.06
2.2
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
51
528
0.97
0.06
1.4
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
32
305
1.05
0.06
2.5
2.3
u/ml
3.2
1484.8
0.89
32
293
(3005033) Fetal Nuchal fold Thickness US
18
192
0.94
0.05
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
49
506
0.97
0.05
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
70
685
1.02
0.04
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
45
437
1.03
0.04
2.2
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
55
563
0.98
0.03
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
44
428
1.03
0.03
2.0
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
231
1.04
0.02
1.0
1.1
u/ml
0.3
1.9
—
5
97
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
138
0.94
0.02
1.2
1.3
mmol/l
14.3
12.3
—
5
46
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
158
0.95
0.02
2.4
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
301
2996
1.01
0.02
1.5
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
13
123
1.06
0.01
13.2
14.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
154
1.04
0.00
1.3
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
23
231
1.00
0.00
1.1
1.3
mmol/l
7.9
7.6
0.15
18
168
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
239
1.00
0.00
1.0
1.1
u/ml
3.4
4.8
—
8
113
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
96
1.04
0.00
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
436
1.01
0.00
2.2
2.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
12.9
—
0
9
(3044007) Cell count panel - Peritoneal fluid
6
63
0.95
0.00
2.8
2.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
53
0.94
0.00
1.2
1.4
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1484.2
—
0
6
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
89
1.01
0.00
1.3
1.1
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.7
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: M13_NECROVASC – Other necrotizing vasculopathies
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).